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ABSTRACT 
Controlled hydrogel dissolution allows for: 1) atraumatic material removal after it 
served its function, 2) site-specific delivery of encapsulated therapeutics (e.g., proteins, 
small molecules), and 3) a tailored administration of an agent with high efficiency. 
Dissolution of covalently crosslinked hydrogels has been accomplished by incorporating 
cleavable moieties that undergo ester hydrolysis or enzymatic degradation. Recently, 
thiol-disulfide exchange, retro Michal-type reactions, retro Diels-Alder reactions, and 
thiol-thioester exchange chemistries have gained attention, as they provide a responsive 
synthetic handle for engineering hydrogel dissolution rates.  
We synthesized, characterized and tested in vivo two on-demand dissolvable 
dendritic thioester hydrogel dressings for second-degree burn care and hemorrhage 
control. The hydrogels are composed of lysine-based dendrons and PEG-based 
crosslinkers, which were prepared in high yields.  
In context of hemorrhage, there is an unmet clinical need for an on-demand 
dissolvable sealant for non-compressible hemorrhage or areas of body not amenable to 
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treatment with a torniquet. In a model of in vivo hemorrhage control of intra-abdominal 
wounds, our hydrogel reduced blood loss by 33% in severe hepatic hemorrhage and by 
22% in aortic injury, as compared to untreated controls.  
There is an unmet clinical need for a second-degree burn dressing that can be 
removed atraumatically and serve as a barrier to bacterial infection. When our hydrogel 
was used as a dressing, local and systemic bacterial proliferation after wound 
contamination was significantly lower than in the untreated group. The total bacterial 
burden of the burn wound in the positive controls was significantly higher than in the 
hydrogel group and the negative controls (1.39x108 ± 8.30x107 CFU/g v. 4.04x103 ± 
3.99x103 CFU/g v. 6.88x102 ± 6.38x102 respectively; P = 0.009). Also, the total systemic 
bacterial burden in the positive controls was significantly higher than the hydrogel group 
and the negative controls (9x102 ± 7.76x107 CFU/g v. 5x101 ± 0 CFU/g v. 5x101 ± 0 
CFU/g, respectively; P = 0.031). 
A unique feature of both hydrogel systems is their capability to be dissolved on-
demand via thiol-thioester exchange reaction with a biocompatible solution following its 
initial application – thus the wound area can be re-exposed to allow for definitive surgical 
care.  
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CHAPTER 1. On-demand dissolution of chemically crosslinked hydrogels 	  
1.1. Introduction 
Hydrogels are three-dimensional, hydrophilic, crosslinked networks that embed 
large amounts of water.1 They can be divided into two groups: physically and chemically 
crosslinked hydrogels.2 Physical hydrogels are based on networks which are formed by 
molecular entanglements and/or secondary forces, including ionic, H-bonding, or 
hydrophobic. They are often termed reversible as they allow for network formation and 
dissolution with introduction of a stimulus such as a change in pH, ionic strength of the 
solution or temperature. Chemical hydrogels, on the other hand, are formed with covalent 
bonds between different macromolecular chains. Both natural (e.g., alginate, chitosan, 
hyaluronic acid, collagen, fibrin, etc.)3-7 and synthetic (e.g., poly(acrylic acid) (PAA), 
poly(ethylene glycol) (PEG), poly(vinyl alcohol) (PVA), polyphosphazene, polypeptides, 
etc.)8-12 polymers have been used to prepare hydrogels.13  
Hydrogels are of interest in the fields of chemistry and biomedical engineering, 
especially for applications in tissue engineering and drug delivery due to their 
biocompatibility and biodegradability.13-16 Materials used in these applications should: 1) 
be synthesized efficiently under relatively mild conditions, 2) have structural and 
mechanical properties appropriate for an intended application, 3) be delivered in a 
minimally invasive manner, 4) be biocompatible, and 5) be easily removable without the 
need for debridement or be biodegradable. Specifically, synthetic hydrogels are appealing 
for biomedical applications as their chemistries and properties are controllable and 
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reproducible, i.e. they can be synthesized with macromonomers of specific molecular 
weights and architectures, degradable or non-degradable linkages, and crosslinking 
modes. These controllable features are key as they affect hydrogel formation kinetics, 
crosslinking density, and material mechanical and dissolution properties.  
Even though there has been a strong focus on the development, characterization 
and applications of various hydrogel systems, little effort has been directed at a controlled 
and/or on-demand dissolution of chemical hydrogels.17-19 Physical hydrogels, even 
though reversible, are weaker than chemically crosslinked materials and cannot be 
exploited for all applications, especially those that require high energy or extended 
application times. Therefore, there is a need to developing dissolvable chemically 
crosslinked hydrogels. Controlled material dissolution is particularly important for: 1) 
atraumatic matrix removal after it served its function, 2) a site-specific delivery of 
encapsulated therapeutic (e.g., proteins, small molecules, and cells), and 3) tailored 
administration of an agent with high efficiency. Dissolution of covalently crosslinked 
hydrogels has been accomplished by incorporating cleavable moieties, which can 
undergo ester hydrolysis or enzymatic degradation.18, 20-25 Recently, thiol-disulfide 
exchange reactions, retro Michael-type additions, retro Diels-Alder reactions, and thiol-
thioester exchange chemistries have been described for hydrogel dissolution and these 
chemistries will be discussed in detail in the following sections, as they provide a 
responsive synthetic handle for engineering hydrogel dissolution rates.  
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1.2. Thiol-disulfide exchange 
The thiol-disulfide reaction is key to a number of important biological processes, 
such as the formation and cleavage of structural cysteine disulfide bonds and disulfide-
mediated redox reactions.26, 27 Mechanistically, the thiol-disulfide exchange consists of 
initial ionization of the thiol to thiolate anion in a basic medium, nucleophilic attack (SN2 
displacement) of the thiolate anion on a sulfur atom of the disulfide moiety, and 
protonation of the product thiolate anion (Scheme 1.1).28, 29 These three steps are 
reversible. From a materials perspective, the reversible thiol-disulfide exchange can be 
triggered to initiate controllable changes in the material properties (e.g., hydrogel 
modulus).30 The reversible crosslinks are usually incorporated into the polymer chains via 
reductively cleavable disulfide groups. The thiol-disulfide exchange reaction is driven 
forward by the excess of thiolate and its pKa. 
The first report of the use of disulfide reduction of polymeric hydrogels described 
the dissolution of polyacrylamide gels for recovery of samples after electrophoresis.31 
Later, the thiol-disulfide chemistry was used to prepare dissolvable hydrogels and for 
determination of molecular weight between crosslinks in the network.32 Vide infra, 
examples of thiol-disulfide exchange reaction as a means to form and subsequently 
dissolve a hydrogel are described. 
Sinko et al. developed doxycycline-loaded hydrogels and evaluated their efficacy 
in the treatment of mustard gas-injured skin in an SKH-1 hairless mouse model.33 The 
hydrogels were formed in situ by covalent intermolecular crosslinking of polymer chains 
through reversible disulfide bonds. The hydrogels were based on 8-arm-PEG-SH (Mw = 
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20 kDa) crosslinked in presence of either H2O2 (H2O2 hydrogel; 2, 8 wt%) or 8-arm-
PEG-S-TP (S-TP hydrogel; 5, 8 wt%) in the stoichiometric ratio of 1:1 in PBS buffer (pH 
8.0) (Figure 1.1). The H2O2 hydrogels formed within 1 min, while the S-TP hydrogels 
gelled rapidly within 10 sec. 
The reversibility of the above hydrogel network was based on a disulfide 
exchange reaction, involving the transfer of existing disulfide bonds to free thiol-
containing moieties present in the reducing agent, glutathione (GSH, 1, 3, 5% w/v in PBS 
at pH 7.4). GSH is the most abundant thiol species in the cytoplasm (circa 0.5-10 mM) 
and a common reducing agent in various biochemical processes. GSH acts as a thiolate 
moiety, cleaves the existing disulfide bonds and, simultaneously, becomes oxidized. This 
thiol-disulfide exchange reaction does not change the total number of disulfide bonds but 
rather reorders the species that form them. In presence of excess GSH, the hydrogel 
dissolution products were 8-arm-PEG-SH, 8-arm-PEG-S-S-G, G-S-S-G and 8-arm-PEG-
SH which may bear either SH or S-S-G termini (Figure 1.2). The cleavage of the 
disulfide bonds occurred within 30-40, 15-20, and 10-15 min when using the 1, 3 and 5% 
w/v GSH dissolution formulations, respectively.  
In addition, additives such as glycerin, polyvinylpyrrolidone, and PEG (Mw = 0.6 
kDa) were shown to prevent hydrogel dehydration and increase its adhesion to skin. The 
H2O2 hydrogels exhibited a swelling degree of <1.0%, whereas the S-TP hydrogels 
swelled to <1.5%.  
To investigate the mechanical properties of the hydrogel, the authors performed 
rheological measurements. Storage modulus, G’, is a measure of the deformation energy 
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stored by the sample during the shear process. G’ represents the elastic behavior of the 
material. Loss modulus, G”, is a measure of the deformation energy used up by the 
sample during the shear process and, therefore, afterwards it is lost from the sample. G” 
represents the viscous behavior of the material. From rheological measurements, G’ > G’’ 
for all hydrogels, indicating elastic character of the materials at the investigated 
frequency range (0.1-10 Hz).   
The in vitro doxycycline release from both the H2O2 and S-TP hydrogels was 
sustained for up to 10 days, with 73-84% of drug released depending on hydrogel 
formulation. The release mechanism depended on the migration of water through the 
network and drug diffusion caused by hydrogel swelling. The injured skin showed 
elevated doxycycline permeability (8.5 mg/cm3) as compared to controls at 24, 72 and 
168 h post-injury with peak permeability at 72 h. After 168 h, doxycycline permeability 
decreased and epidermal re-epithelialization and wound healing were observed. As 
concluded by in vivo and histological studies of murine skin, there was an improved 
wound healing effect of doxycycline-loaded hydrogels (0.25% w/v) on injured skin as 
compared to untreated or placebo-treated skin. Overall, the proposed doxycycline-loaded 
hydrogels offer a promising treatment for dermal wound healing of mustard gas injuries 
with an attractive feature of material dissolution with thiol-containing reducing agent.  
Hisano et al. designed a hydrogel matrix with embedded insulin-releasing islets to 
serve as a bioartificial pancreas.34 The synthesis of the hydrogel commenced with a 
copolymerization of N,N’-bis-acrylcystamine with acrylamide to give a poly(acrylamide), 
P-S-S-P, possessing disulfide bonds (Figure 1.3). Then, the disulfide bonds were reduced 
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using dithiothreitol (DTT), giving a linear and water-soluble P-SH. Subsequent gelation 
occurred by dissolution of the water-soluble P-SH copolymer in PBS buffer at pH 7.4 or 
8.8, allowing the thiols to be air oxidized to disulfide bonds. Alternatively, gelation to P-
S-S-P was induced by a thiol-disulfide exchange reaction between P-SH and low 
molecular weight disulfides, such as 3,3’-dithiodipropionic acid, cystamine, 2-
hydroxyethyl disulfide or glutathione disulfide.  
The rate of hydrogel formation by air oxidation was too slow (24 h) to enclose 
living islets in the hydrogel without damage. On the other hand, the hydrogel (10 wt%) 
formation via thiol-disulfide exchange reaction allowed for an efficient islet 
encapsulation within minutes. In order to avoid islet damage during encapsulation into 
the hydrogel, the authors investigated the cytotoxicity of low molecular weight disulfides. 
No viable cells were detected after 3 h of exposure to cystamine or 2-hydroxyethyl 
disulfide. After 24 h of exposure to 3,3’-dithioproprionic acid, cell viability was greater 
than 70%, and hence this low molecular weight disulfide was used for the hydrogel 
formation.  
When kept in suspension for several months after implantation, the islets can 
gradually lose their function. Therefore, the hydrogel containing deteriorated islets should 
be replaced. To address this issue, the authors optimized the P-S-S-P hydrogel dissolution 
via thiol-disulfide exchange reaction with L-cysteine or GSH (Figure 1.4). The 
dissolution time decreased with increasing thiol concentration, e.g., the material dissolved 
within 1 min when GSH or L-cysteine concentrations were increased from 200 to 600 
µmol/mL. 
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 There were no differences in baseline (non-stimulated) insulin release from the 
hydrogel prepared using 3,3’-dithiodiproprionic acid or free islets. However, in response 
to glucose stimulation, the amount of insulin released from the hydrogel entrapped islets 
was lower than that of free islets. This could be attributed to the slow diffusion process of 
glucose and released insulin through the hydrogel network.  
Szilagyi and co-workers investigated the redox- and pH-responsive cystamine-
modified poly(aspartic acid) that exhibited a reversible gelation and dissolution via thiol-
disulfide exchange reaction (Scheme 1.2).35 The synthesis started with polysuccinimide 
(PSI) reacting with cystamine hydrochloride to give a cystamine-modified PSI. The side 
chains of the cystamine-modified PSI were oxidized in air to disulfide linkages (0.5-6 h), 
forming disulfide crosslinked PSI gels. These gels could be dissolved within 15 min into 
polymer solutions by adding the reducing agent DTT at a concentration of 1 mM. 
Subsequently, re-gelation occurred place in air within 4-6 h. Overall, this process could 
be repeated several times in DMF as cystamine-modified PSIs exhibited a reversible 
response to the redox environment. Next, the poly(aspartic acid) hydrogels (PASP-SS) 
were prepared by the irreversible hydrolysis of the disulfide crosslinked PSI gels in an 
aqueous buffer solution (pH 8). Subsequently, the disulfide crosslinked PASP-SS gels 
were dissolved via disulfide bond cleavage with DTT (1 mM in PBS) in 10 min to a 
PASP-SH polymer solution. In a reverse process, the PASP-SH could be re-gelled via 
oxidation of the thiols to disulfides using 1 M sodium bromate (NaBrO3 in PBS, pH 7.4) 
as the oxidizing agent.  
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As shown by rheological studies, the storage modulus (G’) was measured as a 
function of time after adding the oxidizing agent, NaBrO3, to the aqueous PASP-SH 
polymer solution. The gelation time was measured to be 120 ± 5 sec. Next, the hydrogel 
PASP-SS was dissolved to a polymer solution via a DTT reduction. In the second 
oxidation, the gelation time was comparable (110 ± 7 sec), hence the gelation-dissolution 
can be accomplished for at least two cycles with preservation of the G’. 
Since carboxylic acid repeating units were present in the PASP-SS hydrogels, pH 
dependent swelling was observed. At pH 4.1, the repeating units were protonated and, 
due to the non-ionized PASP chains, the volume and the pore size of the hydrogels 
decreased. However, at pH 8.0, the carboxylic acid moieties were deprotonated, yielding 
a greater pore size and a larger swelling degree. 
Reduction-facilitated release of an entrapped dye from the disulfide crosslinked 
hydrogel, PASP-SS, was studied. In absence of a reducing agent, only 20% of the dye 
was released over the duration of the experiment (120 min). In the presence of DTT, a 
burst release occurred and the total amount of released dye was five times greater as 
compared to the control, with almost 100% release at the end of the experiment. 
However, it was observed that a large amount of dye was released even before the 
reduction-induced dissolution of the hydrogel was completed due to the sudden increase 
in swelling. Further characterization of the release kinetics is warranted to confirm the 
mechanism of release for a potential drug release application.  
These reports describe hydrogels that can be dissolved on-demand with DTT with 
the goal of in vivo applications. This represents an advantage as the built-in redox-
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sensitivity is designed by mimicking the redox processes in living cells; the most widely 
known glutathione-glutathione disulfide redox couple plays an essential role in 
maintaining the redox potentials in the intra- and extracellular media. Despite the above 
materials being synthesized for drug delivery, no data on the cytotoxicity of the hydrogels 
or their dissolution agents are presented. Another unknown is the instability of the thiol-
containing hydrogel precursors that readily oxidize in air. This gives less control over 
reproducibility and material properties as some of the precursors are already oxidized 
before the intended gelation reaction is carried out. 
 
1.3. Retro Michael reaction 
Another class of dissolvable hydrogels is based on materials prepared via 
conjugate addition reaction, i.e. Michael-type addition reaction (Scheme 1.3A).36 One 
common strategy to synthesize the hydrogels employs maleimide-functionalized 
macromonomers crosslinked with various thiol-functionalized PEG multi-arm star 
polymers, yielding a network crosslinked with thioether linkages. The thiol-maleimide 
Michael addition reaction has been widely implemented in biological systems. It is 
primarily due to the selectivity of the thiol-maleimide reaction in aqueous environments 
(at physiological pH, amines react generally at least one order of magnitude slower than 
thiols),37, 38 the rapid kinetics associated with the reaction, and the relative stability of the 
thiol-maleimide product. However, minimal effort has been directed at using the retro 
Michael addition for hydrogel dissolution (Scheme 1.3B). The likely mechanism of this 
reaction consists of the covalent bond transfer from the initial succinimide thioether 
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compound to a stable glutathione conjugate in the presence of excess reductant. It was 
reported that the rate and extent of this reaction, which are governed by the rate of the 
retro-addition, can be modulated by controlling the reactivity of the Michael donor.39 For 
example, aromatic thiols (pKa ~ 7) are better Michael donors than aliphatic thiols (pKa ~ 
11), and are better leaving groups, allowing for a faster dissolution in a reductive 
environment. On the other hand, the use of a Michael donor with sufficiently high pKa 
can hinder the retro reaction. 
Kiick et al. showed that succinimide-thioether linkages, formed via Michael-type 
addition of thiols to maleimides, were cleaved by exogenous GSH.40-42 In their report, 
hydrogels (5 wt%) were formed in situ by mixing solutions of the thiolated four-arm PEG 
(Mw = 10 kDa) and maleimide-functionalized low molecular weight heparin (Mal-
LMWH) prepared individually in phosphate buffered saline (PBS) (Scheme 1.4). 
Hydrogels prepared with alkyl thiol-functionalized PEGs (3-mercaptopropanoic acid, 
MP; 3-mercaptoisobutyric acid, MIB) were gelled at pH 7.0 and temperature of 25 °C, 
and hydrogels prepared with aryl thiol-functionalized PEGs (4-mercaptophenylpropanoic 
acid, MPP; 2,2-dimethyl-3-(4-mercaptophenyl)propionic acid, DMMPP) were gelled at 
pH 6.6 and temperature of 4 °C to slow the gelation and permit mixing before gelation 
occurred.  
Via 1H NMR studies, the authors verified that no thiol oxidation to disulfide 
occurred during the gelation process. A complete disappearance of the maleimide and 
mercaptoacid protons and no appearance of new peaks for disulfide bond or ring-opened 
maleimides were observed. Oscillatory rheology was then used to determine the gelation 
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kinetics and final modulus for all four types of PEG and LMWH hydrogels (PEG-MP, -
MIB, -MPP, and -DMMPP). The gelation occurred in < 6, 15, 50 and 90 sec for PEG-
MPP, -DMMPP, -MP and -MIB hydrogels, respectively. The authors attributed the rate 
of hydrogel gelation to the Michael donor reactivity of the thiols as the phenylthiol 
derivatives have lower pKa values as compared to the alkyl thiols (6.6 vs. 10.3), hence 
they exhibited faster reaction rates. Overall, there was no statistically significant 
difference (ANOVA, p = 0.79) between the measured G’ values for all of the hydrogels 
as their G’ was approximately 2.1 kPa, showing that the identity of the thiol derivative 
does not impact the final hydrogel modulus. 
1H NMR characterization validated GSH-sensitivity of the PEG-MPP and PEG-
DMMPP hydrogels resulting from retro Michael addition-mediated cleavage of the 
succinimide-thioether bond. The hydrogel samples were formed and then swelled in 
deuterated PBS containing 10 mM GSH and the liberated dissolution products containing 
thiols were detected in solution. At day 4, most of the succinimide-thioether linkages 
have degraded, mainly yielding the PEG-MPP. Hydrogels incubated in the absence of 
GSH did not show the disappearance of the peaks from soluble MEG-MPP.  
Next, using rheological measurements (oscillatory stress sweep), the authors 
assessed both the kinetics of hydrogel dissolution and the changes in their mechanical 
properties due to dissolution in presence of GSH-containing buffer. Under highly 
reducing conditions (10 mM GSH), the PEG-DMMPP dissolved in approximately 90 h, 
while the PEG-MMP dissolved in circa 72 h. Interestingly, the PEG-MMP- and PEG-
DMMPP-containing hydrogels exhibited a lower susceptibility to GSH than disulfide-
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containing hydrogels (consistent with the rate constants for the retro Michael-type 
addition being one order of magnitude lower than those for glutathione-disulfide 
exchange).39	  
In addition, heparin release was assessed as a function of hydrogel dissolution. 
The concentration of heparin released from the hydrogels into solution was measured 
using established metachromatic dye protocol. The hydrogels containing the GSH-
sensitive succinimide-thioether linkages, i.e. PEG-MPP and PEG-DMMPP, released 
100% LMWH in 12 and 20 days under standard reducing conditions (10 µM GSH), 
respectively. Under highly reducing conditions, the PEG-MPP and PEG-DMMPP 
hydrogels dissolved rapidly with a 100% LMWH release in three and four days, 
respectively. The release profiles of PEG-MP and PEG-MIB hydrogels showed 
significantly less sensitivity to reducing conditions requiring 20 (PEG-MP) and 49 days 
(PEG-MIB) under standard conditions, and 17 (PEG-MP) and 33 days (PEG-MIB) under 
high reducing conditions (in their previous studies, the authors did not observe a retro 
Michael-type reactions for PEG-MP- and PEG-MIB-containing substrates).39 
In a more recent report, Kiick and co-workers described a hydrogel which can be 
dissolved via three different modes of controlled degradation: ester hydrolysis in 
response to an aqueous environment, retro Michael-type reaction with thiol-exchange in 
response to GSH reducing environment, and photocleavage in response to externally 
applied light (Figure 1.5).43, 44 In this system, a 4-arm-PEG end-functionalized with aryl 
thiols (PEG-4-arylSH) was reacted with 4-arm photodegradable PEG end-functionalized 
with maleimides (PEG-4-PD-Mal) via a Michal-type addition reaction. The reported 
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hydrogels (5 wt%) were formed in situ within seconds by mixing precursor solutions of 
photodegradable PEG-4-PD-Mal and microenvironment-sensitive PEG-4-arylSH at 1:1 
ratio of maleimide to thiol.  
Crosslinking of the photodegradable and thiol-sensitive PEG macromonomers 
yielded a hydrogel whose key functional units for dissolution were o-nitrobenzyl ether (o-
NB) and mercaptophenylacetic acid (MPA)-based thioether succinimide linkages, 
respectively. The o-NB photolabile group was utilized due to its susceptibility to 
degradation over a wide range of cytocompatible irradiation conditions, including long 
wavelength UV, visible, and two-photon IR light. Upon the application of cytocompatible 
light, the photolabile o-NB linkage underwent irreversible cleavage, resulting from 
photochemically induced photoisomerization, giving ketone and carboxylic acid-based 
cleavage products (Scheme 1.5). 
Rheological studies highlight the elastic nature of the hydrogel as the G’ was 
measured to be 0.2 and 3.7 kPa for 2 and 5 wt% hydrogels, respectively.  
Next, the dissolution of the hydrogels in response to different stimuli (Scheme 
1.5) was investigated by monitoring the changes in G’ as a function of time. When 
exposed to low doses of light (long wavelength UV, 10 mW/cm2 at 365 nm, 30 sec 
pulse), the hydrogels exhibited a rapid decrease in the modulus, and a complete 
degradation was noted after approximately 4.5 min of continuous exposure. In response 
to the same light exposure, the negative hydrogels, which lack the photodegradable group 
(formed with PEG-4-alkylSH and PEG-4-Mal), exhibited no significant change in 
modulus with time. The hydrogels also exhibited responsiveness when exposed to low 
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intensity visible light (10 mW/cm2 at 400-500 nm) with degradation requiring a longer 
time. Additionally, hydrogel dissolution was also investigated in the presence of GSH (10 
mM). A decrease in the modulus of the hydrogels was reported, indicating dissolution 
due to thiol exchange reactions of aryl thiol-based thioether-succinimide linkages with 
GSH under reducing conditions. A complete degradation was observed in approximately 
two days. Furthermore, both macromonomers, i.e. PEG-4-PD-Mal and PEG-4-arylSH, 
contain ester linkages that allow for network dissolution via hydrolysis under aqueous 
conditions. When exposed to PBS (pH 7.4), the hydrogels dissolved in four days due to 
ester linkage hydrolysis. 
Then, the degradation-mediated release of cargo nanobeads was investigated as a 
model system for tailored release. Fluorescent nanobeads (diameter ~100 nm) were 
encapsulated during hydrogel formation. The authors hypothesized that the release of the 
cargo would be controlled by the hydrogel dissolution, as the diameter of the nanobeads 
is approximately 10 times greater than hydrogel mesh size. When exposed to a reducing 
environment of 10 mM GSH, cargo release was observed only after hydrogel dissolution 
(bulk degradation) in two days. When exposed to PBS buffer, the release of nanobeads 
was noted only after hydrogel dissolution in four days due to ester hydrolysis. On the 
other hand, when irradiated with pulses of light (10 mW/cm2 at 365 nm periodically for 
10 min), a light-responsive release was noted with about 6-8% cargo release in response 
to each 10-min light pulse without observable bulk hydrogel degradation (surface 
erosion). In principle, such strategies could be employed for the delivery of multiple 
therapeutics with precise control over the release and delivery of cargo. 
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In summary, the succinimide-thioether bond-containing hydrogels have an 
increased stability as compared to the disulfide-based networks. This provides 
opportunities to utilize these chemistries for a more sustained release of therapeutics 
under highly reducing conditions present in intracellular compartments or tumor 
microenvironments. Unfortunately, the literature reports on dissolution via retro Michael 
reaction are limited to those containing maleimide precursors. Investigation is needed 
into dissolution of hydrogels formed with different Michael acceptors, e.g., acrylates. 
Additionally, GSH-mediated dissolution at highly reductive conditions (10 mM) is not 
immediate. Hence side reaction, such as maleimide ring hydrolysis that results in non-
dissolvable crosslink, will also impact the rate and extent of hydrogel dissolution. 	  
1.4. Retro Diels-Alder reaction 
Another class of dissolvable hydrogels relies on the Diels-Alder (DA) reaction 
and its counterpart, the retro Diels-Alder (rDA) fragmentation, which are reversible under 
certain conditions, such as elevated temperatures (Scheme 1.6).45, 46 Typically, in the DA 
cycloaddition, hydrogels are formed via a highly specific cyclization reaction between a 
conjugated diene and a substituted alkene dienophile in water and in absence of catalysts 
or initiators.47-50 Early examples of incorporation of this reversible reaction chemistry 
within the crosslinks of hydrogels describe network dissolution at temperatures above 60 
°C or by introducing hydrolytically or enzymatically cleavable sites to render the 
hydrogels biodegradable or dissolvable. Furthermore, the majority of systems reported in 
the literature do not readily undergo dissolution at 37 °C due to a low rate of rDA 
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reaction and high crosslinking density of the polymers, thus limiting their translation into 
biological milieus.51, 52 Hydrogel dissolution requires multiple rDA reactions to occur 
simultaneously at a significant rate, which is difficult to achieve in highly crosslinked 
networks. To address those limitations, studies have been undertaken to investigate the 
relationships between novel DA hydrogel systems with temperature and pH. 
One of the earliest reports on hydrogel dissolution via rDA reaction describes a 
hydrogel formed via DA cyclization (Scheme 1.7) between furan pendants of diene 
monomers (prepared by free radical copolymerization of N,N’-dimethylacrylate and 
furfuryl methacrylate) and maleimide terminals of dienophile monomers (prepared by the 
coupling of N-4-(chlorocarbonyl)phenylmaleimide with PEG).53 Hydrogels formed at 15 
wt% did not undergo dissolution in water at 100 °C, however, when exposed to 
dimethylformamide (DMF) at 100 °C, the samples dissolved in 0.4 h. Hydrogel 
dissolution was noted to decrease with decreasing temperature, as at 70 °C, the hydrogel 
samples remained intact. The authors attributed these results to the ability of DMF to trap 
the polymeric diene and dienophile away from each other and preclude network re-
formation.  
In order to address the problem of dissolution at physiologically relevant 
conditions, Finn et al. introduced a class of 7-oxanorbornadiene (OND) crosslinkers 
(Figure 1.6).54 In this system, the OND moiety participates in the hydrogel formation and 
dissolution via conjugate addition and rDA reactions, respectively. The products of the 
addition reactions with ODN moieties undergo fragmentation by rDA reaction at rates 
that can be modulated by varying the OND moiety.  
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In the reported system, PEG-OND hydrogels (3.5 wt%) were prepared by mixing 
4-arm thiol-terminated PEG (4-PEG-SH, Mw = 10 kDa) and OND crosslinkers at 
equimolar concentrations of thiol and electrophile in PBS buffer containing 7% v/v 
dimethyl sulfoxide (DMSO) (Figure 1.6). The hydrogels containing crosslinkers 1a and 
1b formed within 90 sec at pH 7.2 and room temperature, and less than 30 sec at pH 7.4 
and 37 °C. At lower pH of 6.5, the gelation was slower and hydrogels were formed after 
20 min. Oscillatory rheological studies at 37 °C showed G’ > G”, confirming solid-like 
behavior of the hydrogels. Samples formed with cleavable crosslinkers 1a or 1b 
dissolved upon extended heating at 50 °C, whereas hydrogel crosslinked with cleavage-
resistant 2 (prepared by epoxidation of 1a with dimethyldioxirane) remained intact. As 
confirmed with 1H NMR, the OND-thiol adduct hydrogels were dissolved to furan and 
thiomaleate moieties via rDA fragmentation rather than amide hydrolysis.  
Interestingly, the dissolution rates of the PEG-OND hydrogels in the absence of 
swelling buffer were affected by temperature and the identity of the OND crosslinker 
used during hydrogel formation. Hydrogels crosslinked with 1a remained stable for >2 
weeks at 4 °C, but dissolved after 12 h at 37 °C and 3 h at 50 °C. Hydrogels prepared 
with 1b were stable for >60 h at 37 °C and 13 h at 50 °C. Samples obtained by 
crosslinking with 2 remained intact when exposed to experimental temperature range. 
The dissolution of the PEG-OND hydrogels was examined during swelling and by 
labeling 3% of the 4-PEG-SH with a boron-dipyrromethene (BODIPY) fluorescent dye 
via maleimide coupling prior to gelation. The probe-labeled moieties allowed for 
monitoring and comparison of dissolution behavior under biologically relevant 
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conditions. As the hydrogel underwent rDA-mediated dissolution, an increase in 
absorbance (504 nm) of the buffer was recorded. Initially, slow release of the BODIPY-
labeled PEG was noted, followed by rapid dissolution which occurred at later times for 
hydrogels formed with more stable OND adducts (i.e. ~40 h for hydrogel crosslinked 
with 1a and ~160 h for hydrogel prepared with 1b). Interestingly, hydrogels prepared 
using a combination of crosslinkers produced materials with release profiles tuned 
between those of hydrogels prepared from a single crosslinker. The authors also observed 
that the dissolution of the hydrogels was not affected by pH changes (5.0-9.0) of the 
buffer due to the pH-independent nature of the rDA reaction.  
Next, the diffusion of entrapped (as opposed to covalently bonded) cargos out of 
the OND hydrogels (formed with crosslinkers 1a, 1b and 2) was investigated. Three 
cargo model systems were tested: a small molecule (carboxyfluorescein), a globular 
protein (fluorescein-labeled bovine serum albumin, BSA) and a 30 nm protein 
nanoparticle (fluorescein-labeled bacteriophage Qβ virus-like particle). It was observed 
that carboxyfluorescein diffused rapidly from all hydrogels (kdiffusion = 0.66 ± 0.03 h-1), 
whereas BSA diffused at a slower rate (kdiffusion = 0.05 ± 0.01 h-1). In case of the least 
stable hydrogel crosslinked with 1a, the hydrogel dissolution competed with cargo 
diffusion, and BSA release from this hydrogel was faster than from the more stable 
hydrogels. On the other hand, the release of the virus-like nanoparticles was dependent 
on hydrogel dissolution for all samples, indicating that the particle size was greater than 
the hydrogel mesh size. Hence, no release of particles was observed from the cleavage-
resistant hydrogel prepared from crosslinker 2.  
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Another example of rDA fragmentation as a means to dissolve a hydrogel was 
reported by Goepferich and co-workers.55 The authors explored DA hydrogels prepared 
by mixing equal molar amounts of furyl and maleimide-substituted PEGs of the same 
molecular weight and branching factor in water (i.e. 4-arm-PEG10k-hydrogel, 4-arm-
PEG20k-hydrogel, 8-arm-PEG10k-hydrogel, and 8-arm-PEG20k-hydrogel (Scheme 1.8). 
The rheological characterization of the DA hydrogels revealed the gelation time to be 
controlled by the polymer concentration, branching factor, and the molecular weight of 
the macromonomers. The gelation time was reduced by increasing the polymer 
concentration, e.g., increasing the polymer concentration from 5 to 15 wt%, decreased the 
gelation times of 4-arm-PEG10k-hydrogels from 171 ± 25 min to 59 ± 5 min. Increasing 
the degree of branching also decreased the gelation times. When the branching factor was 
doubled (eight vs. four reactive sites), the gelation times of 10 wt% hydrogels decreased 
from 106 ± 14 min for 4-arm-PEG10k-hydrogels to 24 ± 1 min for 8-arm-PEG10k-
hydrogels. Polymers with higher molecular weights exhibited longer gelation times than 
those with lower molecular weights, e.g., doubling the molecular weight of the 
macromonomers increased the gelation times of 15 wt% hydrogels from 14 ± 1 min to 34 
± 1 min.  
Next, oscillatory shear rheological experiments were conducted to measure the 
stiffness of the hydrogels. When the polymer concentration was increased from 5 to 15 
wt%, the absolute value of the complex shear modulus (|G*|) of 4-arm-PEG10k-
hydrogels increased from 2821 ± 1479 Pa to 18950 ± 3511 Pa. Similar trend was 
observed for 8-arm-PEG10k-hydrogels, where |G*| increased from 4973 ± 1798 Pa to 
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37097 ± 6698 Pa and for 8-arm-PEG20k-hydrogels, where |G*| ranged between 2152 ± 
144 Pa and 19057 ± 1002 Pa. Additionally, the mechanical properties were also 
influenced by the branching factor of the macromonomers. The |G*| of the 10 wt% 
hydrogels increased from 8447 ± 2492 Pa to 24797 ± 8678 Pa by using 8-arm-PEG10k-
hydrogels instead of 4-arm-PEG10k-hydrogels. Also, the stiffness of the hydrogels was 
decreased by increasing the molecular weight of the polymers from 10 to 20 kDa, e.g., 
the |G*| of 10 wt% 8-arm-PEG10k-hydrogels was 24797 ± 8678 Pa and 8969 ± 2271 Pa 
for 8-arm-PEG20k-hydrogels. 
In order to confirm that the hydrogel dissolution proceeded via rDA reaction, a 5 
wt% 4-arm-PEG10k-hydrogel was prepared in D2O, swollen in deuterated PBS buffer 
(pD 7.4) until dissolution, and then analyzed by 1H NMR (Scheme 1.9). Immediately 
after mixing the hydrogel precursors, a 1H NMR spectrum showed peaks corresponding 
to that of 4-arm-PEG10k-maleimide and 4-arm-PEG10k-furan. After 72 h of 
crosslinking, peaks corresponding to the cycloaddition product were recorded. However, 
after dissolution, no signals for 4-arm-PEG10k-meleimide were detected, and instead, 
peaks corresponding to the hydrolyzed (ring-open) form of 4-arm-PEG10k-maleimide 
were observed. In addition, due to a higher macromonomer concentration in the 8-arm-
PEG10k-hydrogel than the 4-arm-PEG10k-hydrogel, the dissolution of 8-arm-PEG10k-
hydrogel proceeded slower. The authors noted that at 37 °C, the dynamic equilibrium of 
the DA reaction lied on the side of cycloaddition products, however, a small amount of 
unreacted maleimide and furyl groups was still present. The maleimide groups were free 
to react with furyl groups to form a DA adduct or they could undergo hydrolysis to 
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maleamic acid derivatives that did not form cycloaddition products under the 
experimental conditions (Scheme 1.9). Due to hydrolysis to the unreactive maleamic acid 
derivatives, the existing maleimide groups were continuously removed from the dynamic 
equilibrium and the DA reaction was ultimately reversed. Therefore, the authors 
hypothesized that the average network mesh size and hydrogel swelling capacity 
increased gradually until a critical number of elastically active chains were broken and 
the hydrogel dissolved. Once a macromonomer was released from the network of a 
dissolving hydrogel, more starting material was removed from the equilibrium by 
diffusion into the surrounding buffer, accelerating the rDA reaction independently from 
the hydrolysis of the maleimide groups.  
The initial studies of Goepferich et al. were later supplemented by a mechanical 
investigation by the authors into the dissolution mechanism of the 8-arm-PEG10k-
hydrogels.56 It was noted that the equilibrium of the DA and rDA reaction between 
maleimide and furan is thermally controlled, and at temperatures up to 60 °C, the forward 
(DA) reaction and adduct formation is favored. However, at temperatures above 100 °C, 
the rDA reaction and the regeneration of maleimide and furan is induced. As a result, the 
hydrogel dissolution cannot be solely driven by rDA as the reaction kinetics are too slow 
at 37 °C. The authors attribute the hydrogel dissolution to rDA mechanism in conjunction 
with the ring-opening hydrolysis of the generated maleimide groups. Also, increasing the 
pH of the dissolution medium increases the rate of maleimide group consumption and 
hydrogel dissolution. However, the authors suggest that additional factors, such as 
crosslinking density and the branching factor of the macromonomers, must also be taken 
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into account when analyzing hydrogel dissolution. Overall, after incubation of the 8-arm-
PEG10k-hydrogels at pH 7.4, hydrogel samples dissolved after two days at 50 °C, eight 
days at 40 °C, 36 days at 30 °C, and 98 days at 20 °C.  
In summary, the DA/rDA transformations offer a highly atom economical 
preparation and dissolution of the hydrogels, as no additional agents are needed to 
controllably form and break down the hydrogel network. At the same time, however, a 
relatively timely material dissolution requires elevated temperatures that may limit the in 
vivo applications of herein described hydrogels.  	  
1.5. Thiol-thioester exchange 
Thiol-thioester exchange occurs in water at pH range relevant to biological 
processes, hence it offers the potential to be used in transformations based on self-
assembly where physiological conditions are needed. However, despite being commonly 
encountered in biology, thiol-thioester exchange is less well understood in organic 
synthesis.57 The reaction relies on a thiolate anion reacting with a thioester to form a new 
thiolate and thioester products (Scheme 1.10). In a competing process in water, thioesters 
hydrolyze to give carboxylic acids. The rates of exchange and hydrolysis depend on the 
temperature, pH of the solvent, and acidity of the thiols used. It has been reported that the 
rate-determining step in the thiol-thioester exchange mechanism is determined by the 
relative pKa of the incoming and departing thiols.58 When the pKa of the conjugate acid 
of the nucleophilic thiolate is greater than that of the leaving thiolate, the rate-
determining step is the formation of the tetrahedral intermediate. However, when the pKa 
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of the conjugate acid of the attacking thiolate is lower than that of the leaving thiolate, the 
rate-determining step is the collapse of the tetrahedral intermediate to yield the products. 
Interestingly, although alkyl thioester hydrolysis is thermodynamically favorable, the 
reactions between thioesters and nucleophilic oxygen are relatively slow as compared to 
reactions with nucleophilic sulfur, favoring the formation of the thiol-thioester exchange 
products and not hydrolysis.58 
While hydrogels based on a thiol-disulfide exchange or native chemical ligation 
(NCL) are known,33, 59-61 the Grinstaff group recently reported the first example of 
hydrogel disassembly based on thiol-thioester exchange.62 A dendritic macromonomer63-
73 was selected since the composition, structure and molecular weight can be precisely 
controlled to afford a species with multiple reactive sites to ensure rapid formation of a 
hydrogel. 
As the mechanism behind hydrogel dissolution relies on thiol-thioester exchange, 
a dissolvable thioester-linked hydrogel (PEG-LysSH) as well as a non-dissolvable control 
amide-linked hydrogel (PEG-LysNH2) were prepared. Specifically, a lysine-based 
peptide dendron 1 or 2 possessing four terminal thiols or amines was synthesized in high 
yield (Scheme 1.11). First, the carboxybenzyl-protected (Cbz) generation 1 (G1) lysine 4 
was synthesized following a previously reported procedure.74 A PEG amine (Mw = 2 
kDa) was then introduced on the peptide dendron by a standard peptide coupling reaction 
to enhance aqueous solubility, followed by the catalytic hydrogenolysis of the Cbz 
groups to afford 2. Dendron 1 was prepared by coupling the activated PFP-3-
(tritylthio)propionic acid to dendron 2, followed by the removal of the trityl groups (Tr) 
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using trifluoroacetic acid and triethylsilane (Et3SiH) in dichloromethane (DCM). The 
dendrons were characterized by 1H and 13C NMR spectroscopy, FT-IR, MALDI and 
TGA (Thermogravimetric Analysis).62 
To prepare the dissolvable PEG-LysSH hydrogel, a solution of dendron 1 in 
borate buffer pH 9.0 was reacted with a solution of poly(ethylene glycol disuccinimidyl 
valerate) (3, SVA-PEG-SVA, Mw = 3.4 kDa) in PBS buffer at pH 6.5 (Figure 1.7). The 
ratio of thiol to SVA was 1:1, and the total concentration of polymer in solution was 
either 10 or 30 wt%. A non-dissolvable PEG-LysNH2 hydrogel was also prepared, as 
control, following the same procedure, by mixing dendron 2 with SVA-PEG-SVA 3. 
Hydrophilic gels formed spontaneously within seconds upon mixing the two aqueous 
solutions at either concentration. The hydrogels exhibited viscoelastic properties and 
were transparent. 
Next, the mechanical strength and viscoelastic properties of the hydrogels were 
investigated using rheological measurements. PEG-LysSH and PEG-LysNH2 hydrogels 
at 10 or 30 wt% concentration showed strong elastic properties with low tanδ (<0.1) and 
exhibited G’ greater than loss moduli (G”) at frequencies between 0.1 and 10 Hz 62. 
Before swelling, G’ values for 30 wt% PEG-LysSH (1:3; dissolvable) and PEG-LysNH2 
(2:3; non-dissolvable) hydrogels were 37 and 14 kPa, respectively, at 1 Hz of frequency 
and 50 Pa of oscillatory stress. The increase in modulus was also consistent with the 
increase in the wt% of the polymer, 37 kPa (30 wt%) vs. 6 Pa (10 wt%) for PEG-LysSH 
hydrogel, at 1 Hz frequency. 
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After exposure to 4 mL of PBS buffer at pH 7.4, 30 wt% PEG-LysSH and PEG-
LysNH2 hydrogels swelled up to 400 and 600%, respectively, and reached equilibrium 
after 48 h 62. At swelling equilibrium, the G’ values, decreased by approximately half for 
both hydrogels. For the 10 wt% hydrogels, the G’ also decreased in a similar manner 
after 48 h of exposure to PBS buffer, with the PEG-LysSH hydrogel possessing the 
lowest G’ value (~200 Pa) at 1 Hz of frequency and 50 Pa of oscillatory stress. Overall, 
the rheological data showed that both the dissolvable and non-dissolvable hydrogels, at 
high wt%, exhibited suitable mechanical properties even after swelling for 48 h. 
The dissolution capability of PEG-LysSH and PEG-LysNH2 based hydrogels at 
30 wt% was evaluated to test the hypothesis that thiol-thioester exchange between the 
thioester bonds in the hydrogel and a thiolate in aqueous solution (e.g., cysteine) would 
dissolve the hydrogel and form an amide linkage to prevent hydrogel re-formation. Three 
conditions were examined: 1) a solution of L-cysteine methyl ester (CME) was used as 
nucleophile based on the NCL mechanism, 2) a water-soluble thiolate solution, 2-
mercaptoethanesulfonate (MES), and 3) a L-lysine methyl ester (LME) solution, where 
the amine acts as the nucleophile. In all three conditions, the dissolution of the hydrogel 
was evaluated at equilibrium after swelling in PBS buffer at pH 7.4. The PEG-LysNH2 
hydrogel containing the amide bonds was used as a control. It was observed that the pH 
of the buffer solution as well as the concentration of the thiolate solution played a 
significant role in the rate of exchange, thus in the dissolution time of the thioester 
hydrogel.  
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The authors noted that increasing the concentration of CME solution up to 0.5 M, 
at a constant pH of 7.4, decreased the dissolution time of the hydrogel from t1/2 = 30 min 
to t1/2 = 18 min. Similarly, when increasing the pH to 8.5, at a constant concentration of 
CME solution (0.3 M), the thioester bridges in the gel were rapidly cleaved and the 
hydrogel completely dissolved in t1/2 = 12 min as compared to 25 min at pH 7.4. Upon 
exposure of PEG-LysSH hydrogel to an excess solution of MES (0.3 M) in PBS at pH 
8.5, the dissolution time of the hydrogel was comparable to that with CME, with t1/2 = 10 
min. Interestingly, 0.3 M LME solution in PBS at pH 8.5 did not cleave the thioester 
bridges in the PEG-LysSH hydrogel even after 60 min, demonstrating that a thiol-
thioester exchange is responsible for the dissolution of the hydrogel with CME. As 
expected, reacting the PEG-LysNH2 hydrogel with 0.3 M CME solution at pH 8.5 did not 
dissolve the hydrogel even after 1 h exposure.  
The adherence to ex vivo human skin tissues of the hydrogel was then examined. 
A solution of dendron 1 (or dendron 2 as a control) in borate buffer was mixed with a 
solution of 3 in PBS and quickly applied to the skin. The gel formed within seconds. 
Torsional stress was applied on both hydrogels to test their adherence strength and 
flexibility on the skin. Despite the stress applied, the gels remained intact. Next, the 
dissolution of the thioester hydrogel was investigated upon exposure to 0.3 M CME in 
PBS buffer, at pH 8.5. After 30 min, PEG-LysSH hydrogel was completely dissolved and 
washed off, while PEG-LysNH2 swelled and remained adhered to the skin even after 
several hours. 
	  	  
27 
Additionally, the authors investigated if the PEG-LysSH hydrogel is able to 
effectively seal punctures in an ex vivo bovine jugular vein and then be successfully 
dissolved. An ex vivo testing apparatus was built in which a vein was secured to the 
apparatus and subjected to a 250 mmHg of internal water pressure. Upon puncturing a 2.5 
mm hole in the vain, water leaked and the pressure dropped to 0 mmHg. Once sealed 
with PEG-LysSH hydrogel (30 wt%), the material secured the puncture site within 5 min 
without leakage, as the pressure continuously increased to approximately 250 mmHg. 
Next, the application of CME yielded hydrogel dissolution, a leak and the pressure 
returned to 0 mmHg. 
To assess the safety profile of the material, in vitro cytotoxicity study with PEG-
LysSH hydrogel (30 wt%) was performed with NIH3T3 murine fibroblast cells. After 
exposure to the hydrogel for 24 h, the cell viability was 97 ± 3% and was similar to that 
of the untreated control (p > 0.05). Additionally, to investigate if the hydrogel induces an 
immune response, in vitro macrophage activation was conducted. Macrophages were 
exposed to either the dissolvable hydrogel (30 wt%) for 24 h or lipopolysaccharide 
(LPS). It was observed that the LPS exposure yielded a statistically higher IL-6 response 
than the hydrogel (p < 0.01) and the response to the hydrogel was statistically 
indistinguishable (p > 0.05) to that of control.  Hence, the dissolvable hydrogel (30 wt%) 
did not activate macrophages. 
In summary, thiol-thioester exchange offers a relatively inexpensive means of 
hydrogel dissolution (Sigma-Aldrich, 25 g of CME for $28.60) and has the potential to 
allow for atraumatic hydrogel removal in vivo. However, in order to be used in the clinic, 
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dissolution times need to be decreased to less than 5 min. Also, toxicity of the thiolate 
solution needs to be assessed. More importantly, the in vivo adherence and dissolution of 
the hydrogel when placed on a highly moist wound with high liquid pressures warrants 
investigation.  
 
1.6. Conclusion 
The four major strategies for dissolution of chemically crosslinked hydrogels rely 
on thiol-disulfide exchange, retro Michael addition, retro Diels-Alder reaction, and thiol-
thioester exchange. The major advantage of some of the abovementioned systems is a 
built-in sensitivity to dissolution agents, e.g., hydrogels containing disulfide bridges or 
redox-sensitive sites dissolve in presence of a reducing agent such as GSH. Another 
beneficial feature is atom economy during formation and dissolution of hydrogels with 
retro Diels-Alder transformations as the dissolution proceeds at elevated temperatures 
without addition of any exogenous agents.  
On the other hand, despite being designed for in vivo applications, many of the 
dissolution systems reported in the literature lack cytotoxic data on the hydrogel, the 
dissolution agents, or the byproducts. Another commonly encountered disadvantage is the 
presence of thiols in the hydrogel precursors as they readily air oxidize to disulfides, 
making these moieties unreactive during hydrogel formation. Additionally, in systems 
that utilize GSH as the dissolution agent, the network breakdown proceeds over a 
prolonged period of time and can be accompanied by nonproductive pathways hindering 
the controlled hydrogel dissolution. Therefore, it is of significant interest to the scientific 
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community to investigate hydrogel networks that would allow for a controlled and on-
demand dissolution under biologically relevant conditions and timescales. This is the 
topic and focus of my Ph.D. research.  
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Scheme 1.1. Thiol-disulfide exchange reaction mechanism 
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Scheme 1.2. Synthesis of cystamine-modified PSI, disulfide crosslinked PSI, disulfide 
crosslinked poly(aspartic acid) (PASP-SS) and its reversible thiol-disulfide dissolution 
to PASP-SH polymer solution in aqueous medium 
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Scheme 1.3. A. Thioether bond formation via a Michael addition reaction between 
maleimide and thiol, B. retro Michael reaction in presence of GSH 
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Scheme 1.4. Hydrogel formation using Mal-LMWH and PEG-thiols, and a subsequent 
hydrogel dissolution via retro Michael reaction or ester hydrolysis  
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Scheme 1.5. Stimulus-triggered hydrogel dissolution 
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Scheme 1.6. Hydrogel formation via DA cycloaddition 
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Scheme 1.7. Chemical structure of hydrogel formed via DA reaction and the rDA 
dissolution products 
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Scheme 1.8. Hydrogel formation via DA cycloaddition 
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Scheme 1.9. Potential rDA dissolution pathway of the DA hydrogel 
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Scheme 1.10. Thiol-thioester exchange in NCL 
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Scheme 1.11. Synthetic route to PEG-peptide dendrons 1 and 2 
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Figure 1.1. H2O2 and S-TP hydrogel synthesis 
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Figure 1.2. Possible hydrogel dissolution products 
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Figure 1.3. Hisano’s approach to hydrogel formation and dissolution 
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Figure 1.4. P-S-S-P hydrogel formation and its dissolution 
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Figure 1.5. Multimodal dissolvable hydrogels formed by reacting maleimide and thiol 
end-functionalized 4-arm-PEG precursors 
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Figure 1.6. Formation of the PEG-OND hydrogels and subsequent dissolution 
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Figure 1.7. Hydrogel formation via mixing of dendron and crosslinker 
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CHAPTER 2. A hydrogel sealant for the treatment of severe hepatic and aortic 
trauma with a dissolution feature for post-emergent care 	  
2.1. Introduction 
Hemorrhagic shock is the first cause of preventable death after traumatic injury in 
military personnel75, 76 and the second in civilian populations.77 In actively bleeding 
patients, prompt arrest of hemorrhage is the most important intervention to prevent death 
and reduce the adverse systemic consequences of the inflammatory cascade after initial 
resuscitation.78 In some scenarios, such as trauma sustained in military operations or in 
rural/wilderness settings, surgical care may not be available for several hours. Immediate 
compression of external wounds by a first responder substantially reduces volume loss, 
and limb tourniquets can control hemorrhage and reduce mortality.79, 80 However, the 
majority of uncontrolled hemorrhages leading to death are either non-compressible or not 
amenable to treatment with a tourniquet.76, 81 These wounds are often junctional, as in 
incompressible inguinal bleeding, or intracavitary such as intra-abdominal or intra-pelvic 
bleeding. Therefore, easily applied sealants, hemostatic dressings, or adhesives are 
critically needed to stop severe hemorrhage and prevent death after traumatic injury in 
emergent scenarios.  
The performance of several advanced sealants, adhesives and hemostatic 
dressings was recently evaluated by the US Army Institute of Surgical Research and the 
Naval Medical Research Center. The results, reported by both laboratories, consistently 
show that three agents (WoundStat® [WS], Combat Gauze® [CG], and Celox®) are 
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effective in reducing blood loss and improving survival in large animal models of 
junctional hemorrhage.82-85 However, several safety concerns have been raised as the 
interaction of water with some materials affords an exothermic reaction resulting in burn 
injuries.86 Furthermore, residues of these agents remain in the lumen of the majority of 
treated vessels even after extensive irrigation and debridement.87 Given the clotting 
activity of these agents, their residues promote local or systemic thrombosis,88 and are 
also associated with significant endothelial injury and transmural damage to the vessels 
that render them nonviable for primary surgical repair.87, 89 Finally, the need for extensive 
surgical or mechanical debridement before definitive repair contributes to additional 
blood loss and damage to adjacent uninjured tissues. 
Although hemostatic agents, sealants, and tissue adhesives were originally 
designed for external use, a natural extension of their applications is for control of 
intracavitary bleeding in the chest, abdomen, or pelvis (non-compressible by external 
means). These injuries represent the greatest need as up to one third of potentially 
preventable deaths in both civilian and military trauma are due to non-compressible 
hemorrhage.90 However, with currently clinically available materials, hemostasis is only 
achieved when extrinsic pressure is applied on the wound. The reported clinical research 
for intra-abdominal, intrathoracic or intrapelvic use of dressings is limited to date91 as 
only uncontrolled, off-label experiences for refractory bleeding are reported.92-94  
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2.2. Criteria for an ideal sealant 
Consequently, there is a critical unmet need for a material that: 1) is easily applied 
and forms in situ, 2) is of sufficient mechanical flexibility to accommodate complex 
wound contours and volumes, 3) can be removed atraumatically under controlled 
conditions for definitive surgical care, 4) is biocompatible, and 5) stops severe arterial 
and/or venous bleeding without the need for compression. Herein, we report the synthesis 
and characterization of a hydrogel-based, dissolvable sealant that meets these criteria. Its 
dissolution, based on a thiol-thioester exchange reaction, will allow for staged surgical 
care of injured tissues without the need for debridement of the dressing. Additionally, we 
evaluate its efficacy in reducing intracavitary blood loss in small animal models of severe 
hepatic and aortic injuries in the absence of direct pressure.  
 
2.3. Synthesis of the hydrogel sealant 
The hydrogel sealant is composed of two components: a dendron 1 and a 
crosslinker 2 (Scheme 2.1 and 2.2). A dendritic macromonomer is chosen as it enables 
fine control of the composition, structure and molecular weight and provides a species 
with multiple reactive sites to ensure rapid gelation. As documented in the literature, such 
materials are finding utility in various biomedical applications.15, 62, 71, 95-107 The tri-lysine 
dendron 1 possesses four reactive thiols for rapid gelation with the bifunctional 
maleimide-capped crosslinker. PEG, Mw = 2 kDa, is attached to the focal point of the 
dendritic structure to increase aqueous solubility. The dendron 1 is synthesized following 
a previously reported procedure.62 Briefly (Scheme 2.1), the tri-lysine dendron is coupled 
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to MPEG-amine via a standard peptide coupling reaction with 1-hydroxybenzotriazole 
(HOBt) and N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide (EDCI) and, 
subsequently, the Cbz protecting groups are removed via hydrogenolysis with Pd/C and 
H2. Next, the thiols are introduced by means of a coupling with pentafluorophenol-
activated and trityl-protected (Tr) mercaptopropionic acid. Finally, the Tr protecting 
groups are removed with trifluoroacetic acid (TFA) and triethylsilane (Et3SiH) to give 
free thiols as the nucleophilic moieties on the dendron. The crosslinker 2 is based on PEG 
with two internal thioester linkages and two MAL end-caps (Scheme 2.2). It is 
synthesized by reacting SVA-PEG-SVA, Mw = 3.4 kDa, with thioglycolic acid in the 
presence of DIPEA to introduce two thioester moieties. Next, the macromolecule is 
capped with N-(2-aminoethyl)maleimide groups (MAL) using (benzotriazol-1-
yloxy)tripyrrolidinophosphonium hexafluorophosphate (PyBOP) as the coupling agent in 
the presence of DIPEA. Due to its fast reaction kinetics and high specificity for thiols at 
physiological pH, the MAL reactive group is extensively used in peptide bioconjugate 
chemistry.108 
 
2.4. Hydrogel formation 
To prepare the hydrogel sealant, a solution of the dendron 1 in borate buffer at pH 
9.0 is mixed with a solution of the crosslinker 2 in PBS at pH 6.5. The ratio of thiol to 
MAL is 1:1, and the total concentration of the polymer in solution is 30 wt%. A 
hydrophilic hydrogel dressing forms spontaneously within one second, at room 
temperature, upon mixing the two aqueous solutions in which the thiols of the tri-lysine 
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dendron react with the MAL end-caps of the crosslinker via Michael-type addition 
reaction, resulting in the formation of thioether bonds, giving a crosslinked network 
(Figure 2.1). Due to its instant in situ gelation, the hydrogel does not flow from the 
administration site, and is not diluted with fluid. This feature also allows for application 
on areas difficult to access or junctional wounds not amenable to tourniquet control. In 
addition, the hydrogel dressing is stable to hydrolysis for several days in PBS at pH 7.4. 
 
2.5. Rheological studies 
Rheological studies reveal the mechanical strength and viscoelastic properties of 
the hydrogel sealant. First, the oscillatory stress sweep, performed at a frequency of 1 Hz, 
establishes the linear viscoelastic region (Figure 2.2). Then, the frequency sweep is run 
at a constant oscillatory stress of 50 Pa (value chosen from the linear viscoelastic region) 
and between 0.1 and 5 Hz frequencies, G’ > G”. At a frequency of 1 Hz, the G’ and G” 
values for the hydrogel are ~9,000 and 500 Pa, respectively (Figure 2.3). Since G’ is one 
order of magnitude higher than G”, the hydrogel is more elastic than viscous at the 
investigated frequency range. The hydrogel sealant is transparent and exhibits 
viscoelastic properties that enable flexibility to fit complex wound contours and volumes. 
Previously in our lab, we investigated the mechanical properties versus wt% of 
various hydrogel formulations. Based on these results, we chose a hydrogel at a 
concentration of 30 wt% as an optimal formulation for hemorrhage sealant because it 
provides appropriate mechanical properties to withstand arterial and venous blood 
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pressures while maintaining integrity and adhesion. Also, concentration of 30 wt% allows 
for hydrogel formation within one second.  
 
2.6. Hydrogel dissolution 
To investigate the dissolution feature of the hydrogel sealant, it is first applied to a 
2.5 mm full thickness incision made on the otherwise intact tissue. The sealant prevents 
leaks when the pressure within the system is increased and held at approximately 120 
mmHg. As shown is Figure 2.4, the thioester-containing hydrogel is dissolved only upon 
exposure to CME (0.3 M, pH 8.5) after an average of 9.6 ± 0.59 min. On exposure to 
LME (0.3 M, pH 8.5) or air, the hydrogel remains intact and no hydrogel dissolution is 
observed. In addition, a control non-dissolvable hydrogel that does not possess thioester 
bonds is prepared with a commercially available crosslinker, SVA-PEG-SVA, Mw = 3.4 
kDa, and 3 (Scheme 2.1). After exposure to CME (0.3 M, pH 8.6), the control hydrogel 
does not dissolve. These results confirm that dissolution proceeds via thiol-thioester 
exchange between the thioester present in the hydrogel network and an exogenous 
thiolate solution.105, 109 
 
2.7. In vitro cytoxicity and macrophage activation (Kristie M. Tevis, PhD) 
The viability of cells cultured with hydrogel sealant via transwells for 6 h is 
assessed via MTS assay in triplicate. The cells exposed to the hydrogel sealant exhibit 
100.4 ± 6.2% viability as a percentage of the positive control. 
	  	  
54 
IL-6 concentration was measured using an ELISA assay. The colorimetric ELISA 
signal is translated into IL-6 concentration through a generated standard curve of known 
concentrations of murine IL-6. RAW 264.7 macrophages exposed to LPS and hydrogel 
sealant secret IL-6 to a concentration of 1345 ± 162 pg/mL and 114 ± 46 pg/mL, 
respectively. The significant difference (p = 0.0003) in IL-6 levels in the growth media 
suggests that the hydrogel sealant does not elicit an immune response. 
 
2.8. In vivo experiments 
To demonstrate the efficacy of the hydrogel sealant, it is necessary to establish 
that it reduces bleeding in the absence of direct pressure, thus decreasing blood loss when 
compared with no treatment. Within either the hepatic or aortic injury models, there are 
no differences in the severity of the wounds inflicted (as determined by the mass of 
excised liver normalized by total body weight) or the volume of pre-injury blood loss 
(Table 2.1). Out of the 30 rats used, only three were excluded from the analyses due to 
inadequate pre-operative heparinization (large blood clots are found in the peritoneal 
cavity). All of the excluded animals belonged to the hydrogel sealant arm of the hepatic 
injury model. These quantitative assurances of comparable injuries allow the differences 
observed in blood loss to reflect the efficacy of the hydrogel sealant. The hydrogel 
sealant reduces the post-injury blood loss by 33% in severe hepatic hemorrhage and by 
22% in aortic hemorrhage when compared to untreated controls (p = 0.02 and p = 0.03, 
respectively) (Table 2.1).  
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Other groups have evaluated the efficacy of different sealants, without direct 
pressure, in intracavitary hemorrhage using comparable small animal models of hepatic 
injury.110-112 Similar to our study design, they also use untreated animals as control 
groups. The use of thrombin + collagen, fibrin, or chitosan sealants results in blood loss 
reduction of 24, 53 and 67%, when compared to untreated controls, with the blood loss 
volume quantified at 90, 30 or 60 min after injury induction and sealant application, 
respectively. These prolonged time points complicate result interpretation as all groups 
report mortality in their intervention groups. The reduction in blood loss volume is 
attributed to both the effect of the sealant and cardiac arrest as the latter also decreases 
the total blood loss. Additionally, these time points artificially magnify the effective 
blood loss volume difference between the treatment and control groups, since controls 
will continue to bleed actively until total exsanguination occurs. In contrast, by 
quantifying blood loss at 20 min, we attribute the blood loss reduction to the hydrogel 
sealant because all of the animals in our study are alive at the time of volume 
quantification. In the severe aortic trauma model, previous efforts focused on the time 
necessary to achieve hemostasis and not on the effects on blood volume loss.113 
When interpreting these results, several caveats must be considered. First, in both 
in vivo models, the injuries are designed to be readily exposed, allowing the hydrogel 
sealant easy access to the bleeding organ. This is not an accurate portrayal of an 
emergency scenario of intracavitary hemorrhage. In such settings, the source of bleeding 
is not easily identified and oftentimes is difficult to access. However, an initial 
assessment of efficacy is warranted before testing the hydrogel sealant under strenuous 
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conditions. Additionally, we do not evaluate the effect of the hydrogel sealant on other 
important outcomes such as mortality, due to the short follow-up period (20 min). 
However, it is essential to avoid the effect that confounding factors such as cardiac arrest 
can have on blood loss quantifications. In addition, translation of any solid organ 
hemorrhage model from an animal to human is challenging due to anatomical and 
physiologic differences. 
 
2.9. Conclusion 
The currently used methods for external hemorrhage control are not applicable to 
non-compressible or intracavitary hemorrhage. In order to decrease the mortality of 
severely injured patients, efforts must be directed at the development of materials that 
allow for efficient hemorrhage control in emergent scenarios and subsequent treatment in 
the operating room. Our hydrogel sealant significantly decreases blood loss in hepatic 
and aortic in vivo animal models of hemorrhage and is of comparable efficacy to other 
materials described in the literature. Moreover, it introduces the novel capability of on-
demand dissolution, via thiol-thioester exchange reaction, thus permitting atraumatic 
wound re-exposure during definitive surgical care. This feature is not present in any 
currently available wound sealant systems. The unique hydrogel sealant design 
contributes to the general hydrogel knowledge, and will facilitate the development and 
evaluation of future sealants to address unmet challenges present in emergent fields and 
high-risk surgeries.  
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2.10. Materials and Methods 
2.10.1. Materials 
Chemicals were either used as received or purified according to Purification of 
Common Laboratory Chemicals. All reactions were carried out under nitrogen using 
standard techniques, unless otherwise noted. SVA-PEG-SVA (Mw = 3.4 kDa) was 
purchased from Laysan Bio and all other reagents were purchased from Sigma-Aldrich. 
1H and 13C NMR spectra were recorded on a Varian Mercury 500 MHz spectrometer. 
Chemical shifts for 1H NMR were reported as δ, parts per million (ppm), relative to the 
signal of residual CHCl3 in CDCl3 at 7.26 ppm. Chemical shifts for 13C NMR were 
reported as δ, ppm, relative to the centerline signal of the CDCl3 triplet at 77.0 ppm. 
Proton and carbon assignments were established using spectral data of similar 
compounds. The abbreviations s, t, and tt stand for the resonance multiplicity singlet, 
triplet and triplet of triplets, respectively. MALDI mass spectra were acquired using a 
Voyager MALDI-TOF spectrometer from Applied Biosystems. Positive ion mass spectra 
were acquired in linear mode. 2,5-dihydroxy benzoic acid solution in acetonitrile (1 
mg/mL) was used as a matrix. 0.3-0.5 mg of the crosslinker was mixed to 10 µL of the 
matrix solution and 1 µL of the solution was then deposited on a MALDI plate.  
 
2.10.2. Synthesis and characterization of hydrogel precursors 
The dendron was synthesized following a previously reported procedure.62 The N-
(2-aminoethyl)maleimide was synthesized following a previously reported procedure.114  
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Crosslinker intermediate (Scheme 2.1): A flame-dried round bottom flask was 
equipped with a rubber septum and magnetic stir bar and was charged with SVA-PEG-
SVA (2.94x10-4 mol, 1.0 equiv), thioglycolic acid (8.82x10-4 mol, 3.0 equiv), and N,N’-
diisopropylethylamine (DIPEA, 1.18x10-3 mol, 4.0 equiv). The flask was purged with a 
stream of nitrogen and dry DCM [0.15 M] was added with a syringe. The reaction 
mixture was stirred at room temperature under a nitrogen atmosphere for 16 h. Then, the 
mixture was poured into a separatory funnel containing 25 mL of DCM and 50 mL of a 
saturated citric acid solution. The layers were separated, and the organic layer was 
washed with water, brine and dried over sodium sulphate (Na2SO4). The solvent was 
evaporated under reduced pressure, and the residue was purified by precipitation in 
diethyl ether to afford the desired crosslinker intermediate as a white solid (0.98 g, 98% 
yield). 1H NMR (CDCl3, 500 MHz): δ 3.80-3.44 (overlap, 210H), 2.65 (t, J = 7.4 Hz, 
4H), 1.77 (tt, J = 7.4, 7.4 Hz, 4H), 1.62 (tt, J = 7.6, 6.2 Hz, 4H) ppm; 13C NMR (CDCl3, 
125 MHz): δ 197.3, 169.9, 70.5, 70.1, 43.2, 31.0, 28.6, 22.2 ppm; MALDI-TOF (pos) 
(M+Na+): 3607. 
MAL-PEG-MAL crosslinker 2 (Scheme 2.1): A flame-dried round bottom flask 
was equipped with a rubber septum and magnetic stir bar and was charged with the 
crosslinker intermediate (2.88x10-4 mol, 1.0 equiv), N-(2-aminoethyl)maleimide 
(1.15x10-3 mol, 4.0 equiv), PyBOP (1.15x10-3 mol, 4.0 equiv), and DIPEA (1.15x10-3 
mol, 4.0 equiv). The flask was purged with a stream of nitrogen and dry DCM [0.05 M] 
was added with a syringe. The reaction mixture was stirred at room temperature under a 
nitrogen atmosphere for 16 h. Then, the mixture was added to excess of cold diethyl ether 
	  	  
59 
and filtered. The resulting residue was dissolved in DCM and poured into a separatory 
funnel containing 25 mL of DCM and 50 mL of a saturated citric acid solution. The 
layers were separated, and the organic layer was washed with water, brine and dried over 
Na2SO4. Solvent was evaporated under reduced pressure, and the residue was dissolved 
in water, filtered, and lyophilized to afford the desired MAL-PEG-MAL crosslinker 2 as 
a white solid (0.81 g, 83% yield). 1H NMR (D2O, 500 MHz): δ 6.88 (s, 4H), 3.90-3.38 
(overlap, 210H), 2.75 (t, J = 7.2 Hz, 4H), 1.74 (tt, J = 9.6, 6.7 Hz, 4H), 1.64 (tt, J = 8.2, 
6.2 Hz, 4H) ppm; 13C NMR (CDCl3, 125 MHz): δ 198.8, 170.6, 168.4, 134.1, 69.9, 43.2, 
38.6, 37.0, 32.3, 28.6, 21.9 ppm; MALDI-TOF (pos) (M+Na+): 3896. 
 
2.10.3. Hydrogel formation 
To prepare the hydrogel, the dendron was dissolved in borate buffer at pH 9.0, 
and was mixed with the crosslinker dissolved in PBS buffer at pH 6.5. The ratio of thiol 
(dendron) to the MAL (crosslinker) was 1:1, and the total concentration of the polymer in 
solution was 30 wt%. Hydrophilic gels formed spontaneously within one second upon 
mixing the two aqueous solutions at room temperature as judged by the “inverted tube 
method.”105 
 
2.10.4. Rheological studies 
The rheological measurements were obtained on a TA Instruments RA 1000 
rheometer. Cylindrical hydrogel samples of 9 mm diameter and 3 mm thickness were 
prepared in a precast Teflon mold and analyzed after sitting in a moisture chamber at 23 
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°C for 15 min. All rheological measurements were performed at 23 °C to avoid 
evaporation. The oscillatory stress sweeps of the hydrogel samples were recorded at a 
frequency of 1 Hz. The frequency sweeps were measured at frequencies from 0.1 to 5 Hz 
with a controlled oscillatory stress of 50 Pa. A normal force of 0.5 N was applied to the 
hydrogel using 8 mm steel plate geometry. Data are expressed as mean ± standard 
deviation (SD) (n = 3). The hydrogel exhibited viscoelastic properties.  
 
2.10.5. Ex vivo hydrogel dissolution 
The dissolution of the hydrogel was defined as failure to hold pressure in a closed 
system with mean time to failure is reported in minutes ± SD.   
The testing device consisted of a sensor assembly connected to a cylindrical 
reservoir.115 The sensor assembly contained a flow sensor (FLR-1007, Omega 
Engineering, Stamford, CT, USA) and a pressure sensor (PX-309, Omega Engineering, 
Stamford, CT, USA), which acquired data at a per-second rate and sent it to a data logger 
(DAQPRO-5300, Omega Engineering, Stamford, CT, USA). The sensor assembly was 
connected to the reservoir through polyvinyl chloride (PVC) pressure monitoring lines 
(MX561, Smiths Medical, Dublin, OH, USA) resulting in a closed system. The reservoir 
was lined with ex vivo murine skin, and 0.9% sodium chloride solution was fed into the 
system using a pressure infuser (Infusable, Vital Signs Inc., Totowa, NJ, USA).  
A 2.5 mm incision was made on the otherwise intact tissues and then sealed with 
the hydrogels (n = 3 per group). A thioester-containing hydrogel (“dissolvable hydrogel”) 
was exposed to aqueous CME solution (0.3 M, pH 8.5). Additionally, three groups were 
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included in the tests as controls: 1) dissolvable hydrogel exposed to aqueous LME 
solution (0.3 M, pH 8.5), 2) dissolvable hydrogel exposed to air only, and 3) hydrogel 
with no thioester bonds (“non-dissolvable”) exposed to CME (0.3 M, pH 8.5). Fifteen 
min after application, pressure within the system was increased to a maximum of 120 
mmHg. Hydrogel dissolution was noted by a sudden drop in pressure recordings and 
visible leakage of saline through the puncture site. 
 
2.10.6. In vitro cytotoxicity studies with the hydrogel sealant (William A. Blessing) 
Cell maintenance: NIH3T3 murine fibroblast cells were maintained as 
recommended by ATCC in Dulbecco’s Modified Eagle Media supplemented with 10% 
bovine calf serum. Cells were maintained in a humidified atmosphere at 37 °C and 5% 
CO2. Subconfluent cells were harvested, and 200,000 cells were plated in each well on 
12-well plates for use in in vitro cytotoxicity studies. 
Cytotoxicity studies: Hydrogel sealant samples (n = 3) were prepared in 
polycarbonate transwells with pore size of 0.4 µm. Each hydrogel sealant sample was 
swelled in PBS at pH 7.4, overnight at room temperature. Transwells were inserted into 
wells with preseeded NIH3T3 and the Dulbecco’s Modified Eagle Media was aspirated 
and replaced with additional Opti-MEM Reduced Serum Media to ensure sufficient 
contact with the transwell. The NIH3T3 were exposed to the hydrogel sealant for 6 h 
before cell viability was assayed using a colorimetric MTS (3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) cell proliferation assay. 
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Absorbance was read at 490 nm, and cell viability in each well was calculated as the 
percentage of the positive control absorbance. 
 
2.10.7. Macrophage activation with the hydrogel sealant (William A. Blessing) 
Cell maintenance: RAW 264.7 murine macrophages were maintained as 
recommended by ATCC in Dulbecco’s Modified Eagle Media supplemented with 10% 
fetal bovine serum and 1% penicillin/streptomycin, and were grown at 37 °C with 5% 
CO2 in a humidified incubator. Subconfluent cells were harvested, and 50,000 cells were 
plated in each well on 24-well plates for use in macrophage activation studies. 
Macrophage activation studies: Hydrogel sealant samples (n = 4) were prepared 
in polycarbonate transwells with pore size of 3.0 µm. Each hydrogel sealant sample was 
swelled in PBS at pH 7.4, overnight at room temperature. RAW 264.7 macrophages were 
exposed to either hydrogel sealant via transwell or to lipopolysaccharide (1 µg/mL), a 
component of gram-negative bacteria that elicits a strong immune response. The 
Dulbecco’s Modified Eagle Media was aspirated and replaced with additional Opti-MEM 
Reduced Serum Media to ensure sufficient contact with the transwell. Media samples 
were collected after 6 h and tested for IL-6, a cytokine secreted by macrophages as a 
marker of macrophage activation. IL-6 concentration was determined by a commercially 
available ELISA assay (abcam). 
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2.10.8. In vivo experiments 
Thirty adult female Sprague Dawley rats (220-290 g) were used in this study. All 
animals were maintained in an Association for Assessment and Accreditation of 
Laboratory Animal Care International (AAALAC) accredited facility. The protocol was 
approved by the Institutional Animal Care and Use Committee (IACUC) of the Beth 
Israel Deaconess Medical Center and Boston University (Boston, MA, USA). 
Two experiments were designed and conducted sequentially. In the first 
experiment, 15 rats were divided into two groups and the efficacy of the hydrogel sealant 
was tested in a hepatic injury model110, 116 (n = 10) and compared with no treatment (n = 
5). In the second experiment, 15 rats were divided into two groups and the efficacy of the 
hydrogel sealant was tested in an aortic injury model113 (n = 10) and compared with no 
treatment (n = 5).  
Hepatic injury model: Anesthesia was induced with 5% isoflurane in an 
induction chamber and then maintained with 2% isoflurane administered through a nose 
cone. Body temperature was maintained throughout the procedure with a water-
circulating heating pad. The animals were anticoagulated with 3000 IU/kg of 
unfractionated heparin administered intravenously (IV) through the lateral tail vein 5 min 
before the start of the procedure (our pilot studies demonstrated that a dose of 1000 IU/kg 
was insufficient to induce uncontrolled hemorrhage as the bleeding stopped 
spontaneously).  After confirming the anesthetic plane, a ventral midline laparotomy was 
made, and bleeding was controlled with a handheld electrocautery. Any blood present at 
this point was removed with a pre-weighted 2 x 2” gauze and its blood-soaked weight 
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recorded as pre-injury blood loss. The capsule of the median lobe was scored in three 
spots (lateral, medial, and in the midline), 1 cm from the hepatic border, with the 
handheld cautery.  The portion of the median lobe distal to the marks was sharply excised 
with scissors. The weight of the excised median lobe divided by the total body weight of 
the rat was used as a measure of the injury reproducibility. 
In the intervention group, the hydrogel sealant (1 mL) was applied directly on the 
wound surface 20 sec after the excision, whereas in the control group no treatment was 
administered. The liver was actively bleeding as the hydrogel was applied. The 
abdominal cavity was left open and, after 20 min elapsed, shed blood was collected with 
pre-weighted, 2 x 2” gauzes (post-injury blood loss).   
Aortic injury model: In the aortic injury model, the animals were anticoagulated 
with 1000 IU/kg of unfractionated heparin and underwent midline laparotomy under 
general anesthesia, as previously described. The abdominal aorta was exposed and the 
peritoneal cavity was dried with 2 x 2” gauzes in order to quantify the pre-injury blood 
loss. A 25-gauge needle was inserted into the artery causing severe arterial bleeding. In 
the intervention group, the hydrogel (1 mL) was immediately applied on the actively 
bleeding wound surface, whereas in the control group no treatment was administered. 
The abdominal cavity was left open and, after 20 min elapsed, shed blood was collected 
with pre-weighted, 2 x 2” gauzes for the evaluation of post-injury blood loss. 
Data collection and analysis: The primary endpoint of the in vivo studies was 
post-injury blood loss volume. After each procedure, the blood loss was calculated as the 
difference between blood-soaked sponges minus the weight of pre-weighed dry sponges. 
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Any blood loss was corrected for body weight (mL/kg) and all measures are presented as 
mean ± SD. Differences in group means were determined with the Student’s t-test (Stata 
Ver 13.0, StataCorp, College Station, TX). Statistical significance was assigned at a 
greater than 95% confidence level (α = 0.05).  
Procedural criteria were developed to include only animals that represented a 
consistent challenge to the hydrogel sealant. Animals were eliminated from the study if 
any of the following criteria applied: 1) copious uncontrolled bleeding from a site other 
than the site of injury, 2) inadequate anticoagulation (spontaneous hemorrhage arrest in 
the 20 sec prior to hydrogel application in the hepatic injury model or presence of blood 
clots in the peritoneal cavity after the injury was inflicted), 3) death due to some 
identifiable reason other than hepatic/aortic blood loss, and 4) accidental disruption of the 
hydrogel sealant during the test period or other irreparable procedural error.	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Scheme 2.1. Synthesis of the dendron 
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Scheme 2.2. Synthesis of the crosslinker 2 
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Figure 2.1. A transparent hydrogel is formed upon mixing dendron with the 
crosslinker  
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Figure 2.2. Oscillatory stress sweep of the hydrogel sealant. Data are expressed as 
mean ± SD (n = 3) 
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Figure 2.3. Oscillatory frequency sweep of the hydrogel sealant. Data are expressed as 
mean ± SD (n = 3) 
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Figure 2.4. Hydrogel dissolution is noted by a sudden drop in pressure recordings 
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Table 2.1. Results of in vivo animal model studies 	  
 
Hepatic model Aortic model 
Hydrogel Control P Hydrogel Control P 
n 7 5 – 10 5 – 
BW %  0.3 ± 0.1 0.2 ± 0.1 0.12 – – – 
Pre-injury  
blood loss  3.6 ± 4.4 4.7 ± 3.1 0.66 1.8 ± 0.6 1.8 ± 0.6 0.98 
Post-injury  
blood loss 23.6 ± 8.3 35.2 ± 7.5 0.02 18.0 ± 3.8 23.1 ± 3.8 0.03 
n = number of animals; BW% = excised liver as a fraction of total body 
weight.	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CHAPTER 3. On-demand dissolution of a dendritic hydrogel-based dressing for 
second-degree burn wounds via thiol-thioester exchange reaction 	  
3.1. Introduction 
Each year, more than 300,000 people die from fire-related burn injuries and 
millions suffer from burn-related disabilities with significant psychological, emotional, 
and economic consequences on the survivors and their families.117, 118 Burn injuries (e.g., 
caused by fire, electricity, chemicals, radiation) are among the most challenging to 
manage: significant fluid loss and extensive tissue damage resulting from deep wounds 
impair multiple vital functions performed by the skin.119 Repeated painful dressing 
changes and wound infection, which further increase local tissue damage, pose common 
complications, while systemic inflammatory and immunological responses lead to a 
higher predisposition to life-threatening sepsis and multi-organ failure. Immediate and 
effective clinical treatments are critical to improve patient outcomes and reduce burn 
mortality rates. 
Current second-degree burn wound dressings provide transient physiologic wound 
closure by absorbing wound exudate, preventing wound desiccation, and isolating the 
wound from the environment.120 Selection of a dressing for a second-degree burn is based 
on healing effect, ease of application and removal, dressing change requirements, cost, 
and patient comfort. Various commercially available dressings such as hydrocolloids, 
polyurethane films, silicon coated nylons, biosynthetic skin substitutes, antimicrobial 
(silver and iodine) dressings, fibers, hydrogels and wound dressing pads, along with 
secondary adhesive dressings, are already used for the treatment of burns.120-122 However, 
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currently available dressings adhere to the wound surface, requiring cutting and 
mechanical debridement for a dressing change, leading to traumatization of newly 
epithelialized tissues, delayed healing, and personal suffering in the injured patient.123 
The average duration of a burn dressing change is reported to be 57.6 ± 34.4 min.123 Burn 
specialists estimate that it takes three people 138 min to dress a 10-30% burn, 105 min to 
dress a facial burn and 66 min to change a hand dressing.124 The need for anesthesia 
further increases time and complexity of the procedure – and is routinely done for 
pediatric patients.125 Consequently, new approaches and/or materials that enable facile 
dressing change, while minimizing procedurally induced tissue damage, are needed in the 
clinic.  
 
3.2. Criteria for an ideal second-degree burn dressing 
An ideal second-degree burn dressing should: 1) conform to the irregular shapes 
of a wound and be easily applied to areas difficult to access with conventional pre-shaped 
dressings, 2) possess elasticity to accommodate movement, 3) absorb wound exudate and 
maintain a moist environment of the wound bed, 4) lessen trauma to the wound during 
dressing changes, 5) be biocompatible, and 6) protect the wound from infections. Based 
on these criteria, we designed and synthesized an in situ gelling hydrogel-based dressing 
possessing thioester linkages. We hypothesized that it will seal the burn wound, act as a 
physical barrier to bacterial migration, and dissolve on-demand, via cleavage of the 
thioester linkages, upon addition of a CME solution to the hydrogel.  
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3.3. Synthesis of the hydrogel burn dressing 
The hydrogel dressing is composed of two components: a dendron and a 
crosslinker (Figure 3.1). The use of a dendritic macromonomer enables fine control over 
the composition, structure and molecular weight while providing a multivalent effect. 
Dendritic macromolecules are finding increased uses as carriers for drugs, scaffolds for 
tissue engineering, and precursors for tissue adhesives.15, 62, 71, 95-107 Specifically, the tri-
lysine dendron possesses four reactive amines for rapid gelation with an electrophilic 
bifunctional crosslinker. For increased aqueous solubility, PEG, Mw = 2 kDa, is attached 
to the focal point of the dendritic structure. The dendron was synthesized following a 
previously reported procedure.62 The new crosslinker is based on PEG with two internal 
thioester linkages end-capped with N-hydroxysuccinimide (NHS) groups. It is 
synthesized by reacting SVA-PEG-SVA, Mw = 3.4 kDa, with thioglycolic acid in the 
presence of DIPEA to introduce two thioester moieties. Next, the macromolecule is 
capped with NHS groups using N,N′-dicyclohexylcarbodiimide (DCC) as the coupling 
agent (see 3.11. Materials and methods). To prepare the hydrogel dressing, a solution of 
the dendron in borate buffer at pH 8.6 is mixed with a solution of the crosslinker in PBS 
at pH 6.5. The molar ratio of amine to NHS is 1:1, and the total concentration of the 
polymer in solution is 40 wt%. A hydrophilic hydrogel dressing forms spontaneously 
within seconds upon mixing the two aqueous solutions in which the amines of the tri-
lysine dendron react with the NHS-esters of the crosslinker, resulting in the formation of 
amide bonds, giving a crosslinked network (Figure 3.1). Due to its in situ gelation, the 
hydrogel can be easily applied to areas difficult to access with conventional pre-formed 
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dressings and also conform to irregular shapes of a wound. Importantly, the hydrogel 
dressing is stable to hydrolysis for several days in PBS at pH 7.4.  
 
3.4. Rheological studies 
In order to determine the viscoelastic properties and mechanical strength of the 
hydrogel, rheological studies were performed. First, the oscillatory stress sweep was 
evaluated in order to determine the viscoelastic region of the material, i.e. region where 
the properties observed are independent of imposed stress or strain levels. Thus, the G’ 
and G” moduli were plotted as a function of the oscillatory stress at a constant frequency 
of 1 Hz (Figure 3.2). Then, the frequency sweep was run at oscillatory stress of 50 Pa 
(value chosen from the linear viscoelastic region). At frequencies between 0.1 and 10 Hz, 
the hydrogel exhibited gel character as G’ > G”. At frequency of 1 Hz, the G’ and G” 
values for the hydrogel were ~13,000 and 500 Pa, respectively (Figure 3.3). Physically, 
the hydrogel exhibits elasticity, is soft to the touch and transparent. 
 
3.5. Swelling 
The ability of the hydrogel to hold water translates to its capacity to absorb wound 
exudate and maintain a moist environment of the wound bed. After exposure to an excess 
of PBS at pH 7.4, the hydrogel swells to 174% in 1 h and 650% in 18 h, reaching 
equilibrium, while maintaining its integrity (Figures 3.4 and 3.5). 
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3.6. Adhesive properties 
Next, the adhesive properties of the hydrogel were measured using an established 
lap-shear by tension loading test (American Society for Testing and Materials, F2255-05). 
Two portions of murine skin were adhered together using the hydrogel and upon 
increasing shear stress, rupture of the hydrogel occurred within the bulk of the material, 
rather than at the tissue-hydrogel interface. Control experiments performed with only the 
dendron or crosslinker solutions did not afford a seal, and the tissue portions remained 
separated (see 3.11. Materials and methods). 
 
3.7. On-demand dissolution 
Unlike other types of trauma, in which pain diminishes over time, the 
interventions, i.e. burn dressing changes, necessary to prevent infection and promote 
healing, worsen the pain of burn injury. As documented in the literature, procedural pain 
is more severe than background pain and can be excruciating without adequate analgesia. 
Hence, our goal is to design a hydrogel dressing which dissolves on-demand, eliminating 
the need for mechanical and/or surgical debridement. The dissolution mechanism 
proceeds via thiol-thioester exchange between the thioester present in the hydrogel 
network and an exogenous thiolate solution.105, 109 Using quantitative rheological 
measurements (Figure 3.6), a time sweep was run in which the thioester-containing 
hydrogel was exposed to CME (0.3 M, pH 8.6). After 30 min of exposure, the hydrogel 
was dissolved (G’ < 200 Pa). As expected, when in contact with LME solution (0.3 M, 
pH 8.5) or air, the mechanical properties of the hydrogel remained unchanged and no 
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hydrogel dissolution was observed. In addition, a control hydrogel sample was prepared 
with a commercially available crosslinker, SVA-PEG-SVA, Mw = 3.4 kDa, which does 
not possess thioester bonds, and subjected to CME (0.3 M, pH 8.6). After 1 h of 
exposure, the control hydrogel did not dissolve confirming that the thiol-thioester 
exchange is responsible for the hydrogel dissolution. We were also able to observe the 
on-demand dissolution of the hydrogel (Figure 3.7). The hydrogel was applied to a 
second-degree burn wound on a rat and left to gel for 1 h (3.7a), after which a CME-
soaked gauze was administered to half of the hydrogel (3.7b). As time elapsed (3.7c-e), 
new CME-soaked gauzes were introduced until complete hydrogel dissolution occurred 
(30 min, (3.7f)). Together, these results show that the ability of the hydrogel to be 
dissolved on-demand provides a desirable alternative to debridement of the dressing. 
 
3.8. In vitro cytoxicity and macrophage activation (Kristie M. Tevis, PhD) 
In vitro cytotoxicity and immunogenicity of the hydrogel were evaluated to 
determine its biocompatibility. The viability of hydrogel-exposed NIH3T3 murine 
fibroblasts did not differ from untreated controls after a 24 h incubation period (91 ± 1% 
v. 100 ± 6%, respectively; p = 0.109).  The expression of IL-6 among RAW 264.7 
macrophages exposed to the hydrogel did not differ from media-only controls (6 ± 4 v. -1 
± 2 pg/mL, respectively; p = 0.20) and was significantly lower than positive controls 
exposed to lipopolysaccharide (LPS) (6 ± 4 v. 2610 ± 21 pg/mL, respectively; p = 
3.14x10-11) (see 3.11. Materials and methods). 
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3.9. In vivo experiments 
A major cause of death of severely burned patients is infection. The avascularity 
of the eschar (a scab formed after a burn injury), which prevents the delivery of immune 
cells, humoral factors, and antibiotics, as well as the presence of coagulated proteins and 
other microbial nutrients provide an optimal environment for bacterial growth and the 
development of infection. Thus, the efficacy of the hydrogel in preventing wound 
infection and sepsis was evaluated in an animal model of second-degree burn.126 Animal 
experiments in this study were approved by the Institutional Animal Care and Use 
Committee (IACUC) at Beth Israel Deaconess Medical Center and Boston University. 
Second-degree burns, covering approximately 5% of total body surface area (TBSA), 
were induced under general anesthesia on 30 adult female Sprague-Dawley rats. 
Immediately after burn induction, the animals were divided into three groups: 1) burn 
only (negative controls, n = 10), 2) burn + bacterial contamination (positive controls, n = 
10), or 3) burn + hydrogel + bacterial contamination (hydrogel-treated group, n = 10). 
Bacterial contamination in the positive controls and hydrogel-treated group was achieved 
by covering the burn and the burn + hydrogel wounds with a gauze containing 2x108 
CFU (colony forming units) of log-phase Pseudomonas aeruginosa (Strain PAO1, ATCC 
47085), respectively.127 P. aeruginosa is the most common source of burn infections.128 
The rats were euthanized 72 h later, and bacterial counts were taken from the eschar (as a 
measure of local proliferation) and from the spleen (as a measure of systemic 
dissemination).129 
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The hydrogel prevented the occurrence of detectable local infections (defined as 
those with >100 CFU/g of tissue) as their prevalence did not differ from the negative 
controls (20 ± 17% v. 0 ± %; p = 0.29) but was significantly decreased compared to 
positive controls (20 ± 17% v. 100 ± 0%; p = 0.001) (Figure 3.8). Additionally, the total 
bacterial burden of the wound in the positive controls was significantly higher than in the 
hydrogel group and the negative controls (1.39x108 ± 8.30x107 CFU/g v. 4.04x103 ± 
3.99x103 CFU/g v. 6.88x102 ± 6.38x102 respectively; p = 0.009). The hydrogel also 
prevented detectable systemic infections (sepsis) when compared to positive controls (0 ± 
0% v. 60 ± 21%; p = 0.038). The total systemic bacterial burden in the positive controls 
was significantly higher than the hydrogel group and the negative controls (9x102 ± 
7.76x107 CFU/g v. 5x101 ± 0 CFU/g v. 5x101 ± 0 CFU/g, respectively; p = 0.031).  
 
3.10. Conclusion 
From a clinical perspective, designing a hydrogel dressing that seals the wound, 
prevents bacterial infection, and dissolves on-demand for atraumatic removal offers 
significant promise for a more effective treatment for second-degree burn patients. From 
a chemistry perspective, the use of a chemoselective transformation, i.e. thiol-thioester 
exchange, to site-specifically cleave the polymer network provides a unique approach to 
controlled dissolution of a material as opposed to the more mainstream activities of 
material formation.  
We synthesized a PEG-based crosslinker and a lysine-based dendritic 
macromonomer in high yields and on gram scales. The hydrogel forms within one minute 
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of mixing the precursors and is easily applied to second-degree burn wounds in rats. 
Additionally, the hydrogel is elastic to accommodate movement, soft to the touch and 
transparent. It adheres well to in vivo animal skin, and swells to 174% in 1 h and 650% in 
16 h, reaching equilibrium. The hydrogel is non-cytotoxic and can be removed on-
demand with CME solution (0.3 M, pH 8.5) in 30 min. Importantly, the hydrogel 
prevents local and systemic infections in vivo.  
 
3.11. Materials and methods 
3.11.1. General information 
Chemicals were either used as received or purified according to Purification of 
Common Laboratory Chemicals. All reactions were carried out under nitrogen using 
standard techniques, unless otherwise noted. SVA-PEG-SVA (Mw = 3.4 kDa) was 
purchased from Laysan Bio. 1H and 13C NMR spectra were recorded on a Varian 
Mercury 500 MHz spectrometer. Chemical shifts for 1H NMR were reported as δ, ppm, 
relative to the signal of residual CHCl3 in CDCl3 at 7.26 ppm. Chemical shifts for 13C 
NMR were reported as δ, ppm, relative to the center line signal of the CDCl3 triplet at 
77.0 ppm. Proton and carbon assignments were established using spectral data of similar 
compounds. The abbreviations s, t, and tt stand for the resonance multiplicity singlet, 
triplet and triplet of triplets, respectively. Infrared spectra were recorded on a Nicolet 
Nexus 670 FT-IR with ATR spectrophotometer. Absorptions are given in wavenumbers 
(cm-1). TGA measurements were performed using TGA Q50. Samples were heated from 
20 to 500 °C at a heating rate of 10 °C/min. Samples were also tested with Differential 
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Scanning Calorimetry (DSC) at a heating rate of 10 °C/min and a cooling rate of 10 
°C/min from -50 to 150 °C. The weight of samples was between 2 to 10 mg and the 
samples underwent three heat-cool-heat cycles. Polymer molecular weights were 
determined by gel permeation chromatography (GPC) versus polystyrene standards using 
DMF as the eluent at a flow rate of 1.0 mL/min through Styragel column (HR4E THF, 
7.8 x 300 mm) with a refractive index detector. Adhesion measurements were obtained 
using an Instron 5848 Microtester with a 100 N load cell. 
 
3.11.2. Synthesis and characterization of compounds 
Dendron: The dendron was synthesized following a previously reported 
procedure.62 
Intermediate A (Scheme 3.1): A flame-dried 10 mL round bottom flask was 
equipped with a rubber septum and magnetic stir bar and was charged with SVA-PEG-
SVA (5.88x10-4 mol, 1.0 equiv), thioglycolic acid (1.76x10-3 mol, 3.0 equiv), and DIPEA 
(2.35x10-3 mol, 4.0 equiv). The flask was purged with a stream of nitrogen and dry DCM 
(4.0 mL) was added with a syringe. The reaction mixture was stirred at room temperature 
under nitrogen atmosphere for 16 h. Then, the mixture was poured into a separatory 
funnel containing 25 mL of DCM and 50 mL of saturated citric acid solution. The layers 
were separated, and the organic layer layer was washed with water, brine and dried over 
Na2SO4. Solvent was evaporated under reduced pressure, and the residue was purified by 
precipitation in diethyl ether to afford the desired intermediate A as a white solid (1.811 
g, 92% yield). 1H NMR (CDCl3, 500 MHz): δ 3.80-3.44 (overlap, 210H), 2.65 (t, J = 7.4 
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Hz, 4H), 1.77 (tt, J = 7.4, 7.4 Hz, 4H), 1.62 (tt, J = 7.6, 6.2 Hz, 4H) ppm; 13C NMR 
(CDCl3, 125 MHz): δ 197.3, 169.9, 70.5, 70.1, 43.2, 31.0, 28.6, 22.2 ppm. 
Crosslinker (Scheme 3.1): A flame-dried 10 mL round bottom flask was 
equipped with a rubber septum and magnetic stir bar and was charged with intermediate 
A (5.40x10-4 mol, 1.0 equiv), NHS (1.19x10-3 mol, 2.2 equiv), and DCC (1.19x10-3 mol, 
2.2 equiv). The flask was purged with a stream of nitrogen and dry DCM (18.0 mL) was 
added with a syringe. The reaction mixture was stirred at room temperature under 
nitrogen atmosphere for 16 h. Then, the reaction mixture was filtered twice to remove 
DCU. Solvent was evaporated under reduced pressure, and the residue was purified by 
precipitation in diethyl ether to afford the desired crosslinker as a white solid (1.688 g, 
88% yield). 1H NMR (CDCl3, 500 MHz): δ 3.98 (s, 4H), 3.81-3.43 (overlap, 210H), 2.84 
(s, 8H), 2.68 (t, J = 7.5 Hz, 4H), 1.78 (tt, J = 7.4, 7.4 Hz, 4H), 1.62 (tt, J = 6.8, 6.8 Hz, 
4H) ppm; 13C NMR (CDCl3, 125 MHz): δ 195.9, 168.6, 164.8, 70.7, 70.2, 43.3, 28.8, 
28.1, 25.6, 22.3 ppm; IR (neat): vmax 3573, 2883, 1742, 1467, 1343, 1107, 961, 842 cm-1; 
mp (DSC): 21 °C; Tdecomp5/50 (TGA): 233/372 °C; GPC (DMF): Mn = 3237 g/mol, Mw 
= 3733 g/mol, PDI = 1.15. 
 
3.11.3. Mechanical properties of the hydrogel 
The rheological measurements were obtained on a TA Instruments RA 1000 
rheometer. To prepare the hydrogel samples, the dendron was dissolved in borate buffer 
at pH 8.6, and was reacted with the crosslinker which was dissolved in PBS buffer at pH 
6.5. The ratio of amine (dendron) to the NHS (crosslinker) was 1:1, and the total 
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concentration of the polymer in solution was 40 wt%. Hydrophilic gels formed 
spontaneously within 3 to 10 sec upon mixing the two aqueous solutions. Cylindrical 
hydrogel samples of 9 mm diameter and 3 mm thickness were prepared in a precast 
Teflon mold and analyzed after sitting in a moisture chamber at 23 °C for 1 h. All 
rheological measurements were performed at 20 °C to avoid evaporation. The oscillatory 
stress sweeps of the hydrogel samples were recorded at a frequency of 1 Hz. The 
frequency sweeps were measured at frequencies from 0.1 to 10 Hz with a controlled 
oscillatory stress of 50 Pa. A normal force of 0.2 N was applied to the hydrogel using 8 
mm steel plate geometry. Data are expressed as mean ± SD (n = 5). The hydrogel 
exhibited viscoelastic properties.  
Equilibrium swelling degree: Cylindrical hydrogels (9 mm diameter, 3 mm 
thickness) were immersed in 6 mL of PBS (10 mM at pH 7.4) for 18 h. Equilibrium 
weights were measured using a milligram precision scale. The equilibrium conditions 
were obtained after three consecutive measurements and were averaged. After swelling 
for 18 h, the G’ of the hydrogel was 430 Pa at frequency of 1 Hz and oscillatory stress of 
50 Pa (40 wt%, n = 3). The equilibrium swelling degree (ESD) was calculated by 
dividing the difference in weight between hydrogel at equilibrium (Weq) and hydrogel 
right after gelation (W0) by its weight right after gelation (W0).  
 
𝐸𝑆𝐷 =    (𝑊!" −𝑊!)𝑊!    ∙ 100% 
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After exposure to PBS buffer (10 mM, pH 7.4), hydrogel swells to 650% and 
reaches equilibrium after 18 h. Data are expressed as mean ± SD (n = 3). Frequency 
sweep of the hydrogel was measured after 18 h of swelling at 50 Pa oscillatory stress 
using a 12 mm diameter steel plate.  
 
3.11.4. In vitro cytotoxicity studies of the hydrogel (Kristie M. Tevis, PhD) 
NIH3T3 cells, a murine fibroblast line was cultured in DMEM media 
supplemented with 10% fetal calf serum and penicillin/streptomycin (1%, 10,000 IU/mL 
penicillin; 10,000 mg/mL streptomycin) and grown at 37°C with 5% CO2. Hydrogel 
samples (n = 3) swelled for 30 min at room temperature in transwell inserts. Prior to cell 
exposure, the samples were soaked in PBS overnight. After 24 h exposure, cell viability 
was judged via the colorimetric MTS cell proliferation assay, with absorbance read at 490 
nm. Exposure to the hydrogel did not result in a statistically lower viability (p > 0.05). 
 
3.11.5. Macrophage activation (Kristie M. Tevis, PhD) 
RAW 264.7 cells, a murine macrophage line was cultured in DMEM media 
supplemented with 10% fetal bovine serum and penicillin/streptomycin (1%, 10,000 
IU/mL penicillin; 10,000 mg/mL streptomycin) grown at 37°C with 5% CO2. The 
hydrogel samples (n = 3) were swelled for 30 min at room temperature in transwell 
inserts. Prior to cell exposure they were soaked in PBS overnight. Macrophages were 
exposed to hydrogels for 24 h via a transwell insert, or 1 µg/mL LPS dissolved in the 
media. Media samples were taken after 24 h exposure and tested for IL-6, a cytokine 
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secreted by macrophages indicating macrophage activation. Presence was quantified via 
an ELISA assay with absorbance read at 450 nm. LPS had a calorimetric signal, 
statistically higher than the hydrogel (p < 0.01) indicative of the presence of IL-6, 
whereas the hydrogel’s signal was statistically indistinguishable (p > 0.05) to that of a 
media control. Therefore the lack of IL-6 presence demonstrates that the hydrogel does 
not activate macrophages. 
 
3.11.6. NMR spectra 
NMR spectra for the intermediate A and the crosslinker are presented in Figures 
3.9 - 3.12. 
 
3.11.7. Evaluation of hydrogel’s adhesive properties 
The tests were performed based on the ASTM F2255-05 standard. The width of 
the tissue specimen was 2.5 ± 0.1 cm. The overlap area between two tissue specimens 
was 1.0 ± 0.1 cm. The thickness of the tissue specimens was 1.0-2.0 mm. The length of 
the tissue substrate attached to each specimen holder was 1.5 times the length of the 
overlap area in order to ensure that the failure occurs at the overlap bond and does not 
pull the tissue off the specimen holds. Ten specimens were tested.  
Tissue preparation: The tissue substrate was kept moist at all times. The 
substrate was cut to the dimensions reported in ASTM F2255-05 standard using a 
template and a fresh scalpel blade. 
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Preparation of adhesive bond: 200 µL of hydrogel was used to uniformly coat 
the overlap area without overflow. The two test fixtures were bonded, taking care to keep 
the fixtures aligned to maintain the overlap. The hydrogel was allowed to set for 1 h and 
the samples were kept moist at 23 °C for 1 h. 
Test procedure: The test specimens were placed in the grips of the testing 
machine so that the applied load coincides with the long axis of the specimen. The 
specimen was loaded to failure at a constant crosshead speed of 5 mm/min. The load at 
failure (maximum load sustained) was 0.62 ± 0.30 N and 100% cohesive failure was 
observed. The apparent shear strength is maximum load divided by the bond area and 
was calculated to be 2.48x10-3 ± 1.2x10-3 MPa. 
 
3.11.8. Design of in vivo animal experiments 
General anesthesia was induced with 5% isoflurane in an induction chamber. 
Following induction, anesthesia was maintained with 2% isoflurane for the full length of 
the procedure. Sustained-release buprenorphine (1.2 mg/kg every 72 h) and meloxicam (1 
mg/kg every 24 h) were administered subcutaneously at the time of anesthetic induction 
and at regular intervals thereafter for post-operative analgesia. Body temperature was 
maintained with a water-circulating heating pad. After confirming anesthetic plane, a 3.5 
x 3.5 cm brass block, heated to 100 °C in an azeotropic boiling PEG:H2O (80:20) 
solution, was placed on the shaved skin of the dorsum with 4 N of contact force for 10 s. 
Fluid resuscitation with 0.5 mL of normal saline was administered subcutaneously. The 
burns covered approximately 5% of TBSA. This model results in a superficial partial-
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thickness burn with destruction of the epidermis and limited injury to the the superficial 
papillary dermis.126 
Immediately after burn induction, the animals were divided into three groups: 1) 
burn only (negative control, n = 10), 2) burn + bacterial contamination (postitive control, 
n = 10), or 3) burn + hydrogel + bacterial contamination (intervention group, n = 10). 
Bacterial contamination in the positive control and intervention groups was achieved by 
covering the burn wound with a 2 × 2 cm gauze containing 2x108 CFU of log-phase 
Pseudomonas aeruginosa (Strain PAO1, ATCC 47085).127 Injury was covered with 
Tegaderm (3M Health Care, St. Paul, MN). The infecting bacterial inoculum was 
prepared in brain heart infusion broth (BHI; Becton-Dickinson) at 37 °C for 5–6 h. The 
cells were harvested (optical density of 0.8 at 620 nm), centrifuged and resuspended in 
sterile BHI. The number of infecting bacteria was verified by plating serial dilutions of 
the injected inocula onto BHI agar plates. 
The rats were euthanized 72 h after burn induction and bacterial counts were 
taken from the eschar (as a measure of local proliferation) and from the spleen (as a 
measure of systemic dissemination).129 Samples from each animal’s eschar and spleen 
were harvested with sterile technique, weighed, homogenized, and resuspended in sterile 
saline solution. Bacterial counts of P. aeruginosa per gram of tissue (eschar or spleen) 
were determined by serial dilutions of the sample and by colony counting on the BHI 
agar plates after an overnight incubation. Samples that did not exhibit growth were 
assigned a value of half the minimum detection limit of the assay (1x102 CFU/g). 
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3.11.9. Statistical analysis 
Due to the small sample size in the in vivo burn study, we could not accept the 
normal distribution assumption for eschar and spleen bacterial cultures and therefore 
utilized a Kruskal-Wallis test to compare bacterial counts across groups with post hoc 
Wilcoxon rank-sum tests and Bonferroni correction for mutiple comparisons. Values are 
reported as means ± standard error the mean (SEM). Significance was set at a two-sided 
P value of 0.05. Analyses were performed with Stata (Stata/IC 14.0, StataCorp LP, 
College Station, TX, USA).  
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Scheme 3.1. Synthesis of intermediate A and crosslinker 
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Figure 3.1. A. An idealized crosslinked hydrogel formed by the reaction the dendron 
and crosslinker; B. On-demand dissolution of the hydrogel relies on a thiol-thioester 
exchange reaction upon exposure to a CME solution 
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Figure 3.2. Oscillatory stress sweep of the hydrogel; Data are expressed as mean ± SD 
(n = 5) 
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Figure 3.3. Frequency sweep of the hydrogel; Data are expressed as mean ± SD  
(n = 5) 
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Figure 3.4. Equilibrium swelling degree of the hydrogel; Data are expressed as mean 
± SD (n = 3)  
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Figure 3.5. Frequency sweep of the hydrogel after swelling in PBS buffer (10 mM, 
pH 7.4) until equilibrium (18 h); Data are expressed as mean ± SD (n = 3) 
	  	  
96 
  
 
 
Figure 3.6. Time sweep of hydrogel dissolution after exposure of the hydrogel to 
CME, LME, or air 
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Figure 3.7. Photographs of the dissolution of the hydrogel as a function of time after 
treatment with an aqueous CME solution (0.3 M, pH 8.6). Fast Green FCF was added 
to the hydrogel for visualization 
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Figure 3.8. Local and systemic Pseudomonal burden by group; * p < 0.001; ** p = 
0.013 
	  	  
99 
  
 
 
Figure 3.9. Representative 1H NMR spectrum of intermediate A 
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Figure 3.10. Representative 13C NMR spectrum of intermediate A 
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Figure 3.11. Representative 1H NMR spectrum of the crosslinker 
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Figure 3.12. Representative 13C NMR spectrum of the crosslinker 
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CHAPTER 4. Future directions 
 
The dissolution of chemically crosslinked hydrogels is crucial for atraumatic 
hydrogel removal after it served its function. We explored the dissolution of chemically 
crosslinked hydrogels via thiol-thioester exchange reaction. Two different formulations 
of hydrogels were synthesized, characterized and tested in vivo for applications in 
hemorrhage control and second-degree burn wound management.  
There is a critical unmet need for a sealant for hemorrhage that can control 
bleeding in absence of manual pressure and can be removed atraumatically. We 
successfully prepared a hydrogel that is easily applied and forms in situ, is of sufficient 
mechanical flexibility to accommodate complex wound contours and volumes, can be 
removed atraumatically under controlled conditions for definitive surgical care, is 
biocompatible, and stops severe arterial and/or venous bleeding without the need for 
external compression. The hydrogel dissolution takes place within 10 min upon exposure 
to CME solution (0.3 M, pH 8.5). In a model of in vivo hemorrhage control of intra-
abdominal wounds, the hydrogel sealant reduced blood loss by 33% in severe hepatic 
hemorrhage and by 22% in aortic injury, as compared to untreated controls.  
A different formulation of the hydrogel was tested as a dressing for second-degree 
burn wounds. There is an unmet clinical need for a second-degree burn dressing that can 
be atraumatically applied to and removed from a burn wound, and that can prevent 
bacterial infection. We have prepared and tested a hydrogel dressing that conforms to the 
irregular shapes of a wound and is easily applied to areas difficult to access with 
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conventional pre-shaped dressings, possesses elasticity to accommodate movement, 
absorbs wound exudate and maintains a moist environment of the wound bed, lessens 
trauma to the wound during dressing changes, is biocompatible, and prevents local and 
systemic infections in vivo. The hydrogel can be dissolved on-demand in 30 min with 
CME solution (0.3 M, pH 8.5).  
After gaining experience with these two hydrogels and testing their performance 
in vivo, we now have the opportunity to increase basic knowledge on hydrogels via a 
study of a small library of new formulations. In this investigation, we will develop 
structure-property relationships that describe hydrogel formation and dissolution rates, 
equilibrium modulus, swelling properties with respect to polymer composition and 
structure.  
Additionally, we have assessed the ability of the hydrogel burn wound dressing to 
act as a barrier to bacterial infection. Prior to testing the hydrogel dressing in the clinic, 
we will conduct a study to assess the capability of the second-degree hydrogel dressing 
(dendron 2 and thioester-containing crosslinker, Figure 3.1) to aid in healing of the burn 
wound in a large animal model. 
 
4.1. Effect of structural variations in crosslinker architecture on hydrogel properties 
A small library of hydrogel precursors will be prepared following the methods 
described in the previous chapters. Hydrogels will be prepared at 30 wt%. Amine-capped 
dendron 2 will be used in all tested hydrogel systems. The hydrophobic portion of the 
thioester-containing PEG crosslinker (Mw = 3.4 kDa) will be varied by increasing the 
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number of methylene groups (m = 1, 2, 3, 5; n = 50) between the PEG and the activated 
NHS carboxylic acid (Figure 4.1). This will be done to determine the effect of different 
crosslinker structures on formation and dissolution rates, mechanical and swelling 
properties.  
The crosslinkers will be characterized by 1H and 13C NMR spectroscopy, FT-IR, 
GPC and MALDI. Their purity will be determined by HLPC. The kinetics of gelation and 
dissolution of dendron 2 with different crosslinkers will be evaluated using rheological 
studies. Mechanical properties of the hydrogels will be measured in their relaxed (prior to 
swelling) and swelled states. In addition, the degradation rates will be investigated.  
 
4.2. Evaluation of the effect of the hydrogel burn dressing on wound healing 
progression using an established porcine model of second-degree burns 
In order to establish the efficacy of the dissolvable hydrogel dressing (composed 
of dendron 2 and thioester-containing crosslinker, Figure 4.2) in promoting the healing 
of burn wounds, the effects of the dressing on dermal angiogenesis and granulation tissue 
formation in porcine second-degree burn wounds over 22 days will be evaluated. 
Thermal burns will be inducted using 3.5 cm diameter brass blocks, heated in an 
azeotropic boiling PEG:H2O (80:20) solution, with a contact time of 10 sec, which will 
result in a partial thickness wound (i.e. half the distance into the dermal layer). Twelve 
such wounds will be induced on each animal, six on each side of the dorsal mid-line 
between the shoulders and hip. Treatments will be applied within 30 min after burn 
induction and will include hydrogel, Biobrane®, and saline-soaked gauze. Thus, one 
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animal will have four wounds per treatment group.  
 
Digital pictures will be taken every three days and wound size values for each 
treatment group will be averaged. On day 0 (prior to wounding) and days 1, 4, 7, 10, 13 
and 22 after wounding, excisional biopsies will be taken from each treatment group.  
The primary outcome measures will be 1) percent re-epithelialization of the 
wound, 2) general wound healing, and 3) time and ease of dressing change. The mean 
percent re-epithelialization at days 1, 4, 7, 10, 13 and 22 and the rate of wound infections 
at days 1 and 7 after injury will be determined.  
 
4.3. Outlook 
Changes in the composition of the crosslinker used to prepare hydrogels will give 
rise to materials with different mechanical properties, gelation and dissolution times, and 
swelling. Knowledge of the relationships between these variables and the key property 
measures will be used for the development of structure-property correlations. 
In the context of the second-degree burn dressing, healing progression will be 
compared between the hydrogel and the most effective commercial dressing available, 
Biobrane®, will be investigated. The study in swine will determine the performance of the 
dressing in a large animal model, which is more akin to human patients, and the ability of 
the dressing to be dissolved and re-applied to the wound every three days.  
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Figure 4.1. Structural variations in crosslinker architecture 
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Figure 4.2. Precursors to dissolvable hydrogel dressing for the evaluation of wound 
healing progression in swine 
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